rfhg_194950.1

Basic information about the TSS

---

TSS ID: rfhg_194950.1 Species: human Chr: chr17		Start: 47650169 End: 47650170 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000577918.5:-18 GeneID: 3837 HGNC/MGI_ID: HGNC:6400 UniProt_ID: Nearer transcript ids and distances:

Gene_name: karyopherin subunit beta 1 Gene_symbol: KPNB1 Gene_synonyms: IMB1 IPO1 IPOB Impnb MGC2155 MGC2156 MGC2157 NTF97 Gene_source: HGNC:6400

TATA-Box annotation

---

Distance to TSS:	18
Nearest PromoterID:	ENST00000577918.5
Entrez ID:	ENSG00000108424
Nearest Unigene:	ENST00000578718
Nearest Refseq:
Nearest Ensembl:
Gene Name:	karyopherin subunit beta 1
Gene Alias:
Gene Type:	protein_coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KPNB1 p2@KPNB1 p3@KPNB1 p4@KPNB1 p5@KPNB1 p6@KPNB1 p7@KPNB1 p8@KPNB1 p9@KPNB1
Sample		p1@KPNB1	p2@KPNB1	p3@KPNB1	p4@KPNB1	p5@KPNB1	p6@KPNB1	p7@KPNB1	p8@KPNB1	p9@KPNB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	233.37	52.21	10.71	10.91	7.40	2.92	3.12	0.58	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	220.93	55.64	11.53	11.73	8.70	4.65	3.64	0.61	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	242.87	54.40	9.26	13.31	7.14	3.09	5.02	0.77	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	207.08	59.67	4.78	8.73	4.16	5.61	6.65	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	219.34	61.42	11.25	10.12	5.85	6.30	5.17	0.22	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	236.06	74.62	8.72	8.14	4.65	7.17	6.20	0.78	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	294.58	97.61	8.72	11.33	7.63	10.24	5.45	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	230.84	71.94	8.96	9.45	8.48	6.06	7.27	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	209.23	66.89	9.40	10.26	7.48	7.27	5.98	0.64	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	237.65	71.29	10.43	9.85	3.48	8.11	7.54	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	213.84	59.02	6.87	5.66	4.45	6.47	6.87	2.43	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	230.11	76.84	4.07	8.13	6.10	10.57	5.69	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	186.18	44.49	3.71	5.48	1.61	0.16	0.81	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	168.99	31.12	3.31	3.46	1.35	0.75	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	161.15	35.35	3.95	3.95	1.98	0.66	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	164.22	35.71	1.51	4.53	0.50	0.50	0.50	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	152.23	31.89	1.75	3.49	1.53	0.00	0.87	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	187.71	43.45	0.84	3.80	1.27	0.00	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	194.07	36.79	1.60	5.33	1.07	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	142.02	35.96	2.56	2.86	1.20	1.05	0.75	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	150.89	31.94	3.74	3.07	2.14	0.27	0.80	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	143.80	29.86	2.07	3.11	1.55	0.69	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	148.77	28.82	2.97	2.33	1.03	0.52	0.78	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	134.68	26.94	1.94	3.88	1.46	0.24	0.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	176.21	28.89	2.32	4.39	1.81	0.52	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	150.03	36.40	2.53	3.80	0.63	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	182.42	41.21	0.55	3.30	0.00	1.10	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	144.75	29.00	3.77	4.72	2.36	1.65	0.94	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	131.96	32.47	2.42	3.07	1.29	0.48	0.48	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	128.30	26.60	4.89	3.26	1.99	0.36	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	117.44	26.59	2.09	2.72	1.47	0.63	0.21	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	113.32	27.55	1.95	2.54	2.15	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	134.43	31.44	1.48	3.38	2.11	0.42	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	181.10	38.60	2.14	3.63	2.14	0.16	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	125.84	27.11	3.55	2.99	1.31	0.19	0.56	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	128.00	23.57	4.02	4.79	2.30	0.19	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	120.99	26.37	3.68	4.29	2.25	0.61	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	113.64	22.16	2.22	2.82	1.81	0.60	0.60	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	120.20	24.04	2.70	2.43	2.70	1.35	0.54	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	113.79	24.25	4.08	3.12	2.88	0.24	1.20	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	112.22	18.82	2.35	3.29	1.18	0.47	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	145.81	26.64	3.37	4.10	1.02	0.88	0.29	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	111.56	20.67	4.01	3.80	1.69	1.48	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	140.39	30.07	2.10	4.02	1.57	0.35	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	129.10	21.28	3.01	4.42	2.01	0.60	0.80	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	118.65	23.50	2.79	4.42	0.93	0.70	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	126.19	24.23	2.16	2.64	2.16	0.96	0.96	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	122.80	28.31	3.87	3.87	2.98	0.00	1.49	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	119.69	29.92	1.91	5.51	1.20	0.72	1.68	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	128.40	29.72	2.83	4.45	1.01	0.20	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	126.25	31.56	1.43	5.94	1.43	0.82	0.82	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	109.19	32.02	1.33	4.00	0.22	0.89	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1049.41	55.97	83.95	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.91	22.36	1.06	1.42	1.77	0.35	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	72.90	23.20	0.33	2.65	0.99	1.33	1.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	364.10	97.32	4.19	18.46	2.52	0.84	5.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	177.73	46.38	1.84	6.43	2.76	0.00	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	63.53	20.42	0.65	1.94	0.65	1.94	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	51.71	16.70	0.00	1.93	0.32	0.96	1.61	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	132.33	39.61	1.57	5.97	0.94	0.00	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	56.40	17.63	0.71	2.12	2.82	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	66.73	19.63	0.56	3.36	1.68	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	536.60	108.28	3.98	17.52	2.39	1.59	3.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	154.93	36.36	0.34	7.14	1.02	0.68	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	66.61	18.85	0.97	3.90	0.65	0.65	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	52.54	17.04	1.06	1.77	0.71	0.71	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1115.31	96.98	64.66	48.49	16.16	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	702.88	94.77	47.38	39.49	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	72.64	17.06	0.98	1.95	1.95	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	80.33	20.33	1.98	1.98	1.49	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	77.87	17.36	0.94	3.75	1.41	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	127.51	25.50	1.32	5.96	0.33	0.66	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	62.18	13.61	0.31	1.24	1.55	0.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	78.58	19.26	1.53	2.75	0.92	0.31	0.61	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	82.52	13.78	0.48	2.53	0.95	0.32	0.63	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	85.03	16.20	3.53	1.60	3.05	0.48	0.48	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	115.78	18.58	1.40	3.18	1.65	0.51	0.51	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	52.32	10.46	1.49	0.75	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	74.35	9.71	1.34	1.67	3.01	0.33	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	78.47	12.76	1.28	3.19	1.91	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	30.79	4.40	2.20	3.30	1.10	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	59.61	16.71	3.61	1.81	1.35	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	74.90	13.73	2.09	1.56	1.22	0.35	0.87	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	118.13	20.73	5.28	3.72	1.76	0.39	1.17	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	107.33	16.73	1.54	5.15	1.80	0.26	1.03	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	129.91	21.19	3.35	4.46	2.23	1.67	0.84	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	135.78	21.16	1.76	4.70	2.94	0.59	0.00	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	148.32	33.78	4.99	4.75	2.41	0.72	1.29	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	124.26	24.85	1.29	4.84	2.58	0.00	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	125.83	20.26	2.67	3.73	2.67	0.00	0.00	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	138.55	21.70	1.67	3.34	1.67	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	82.76	16.64	3.74	1.25	1.25	0.83	1.25	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	89.92	16.58	1.51	3.01	2.01	0.25	0.50	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	89.01	18.65	1.96	3.60	1.96	0.65	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	127.88	23.14	1.83	3.65	1.52	0.61	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	51.05	20.33	0.66	1.99	0.88	0.88	0.66	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	22.95	8.61	1.43	0.36	1.08	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	13.18	4.79	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	49.65	10.61	1.44	1.44	0.90	0.54	0.72	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	10.04	0.00	3.35	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	58.35	11.51	0.82	1.64	1.23	0.00	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	98.75	17.16	2.17	1.72	0.92	0.34	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	92.57	17.88	2.45	2.45	1.47	0.24	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	67.39	14.83	1.80	2.25	0.90	0.00	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	99.85	18.23	3.04	2.60	2.60	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	83.47	14.98	2.14	0.00	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	83.70	14.65	2.99	1.49	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	77.14	13.91	0.00	3.79	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	48.85	9.24	1.32	1.32	0.00	0.66	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	79.92	13.32	2.92	1.62	1.30	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	78.16	11.65	1.46	1.94	1.94	0.49	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	85.52	14.25	0.59	1.19	0.59	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	81.73	9.04	3.77	2.64	0.38	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	95.79	10.89	0.73	1.45	0.73	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	52.66	2.51	2.51	2.51	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	75.94	16.14	2.14	2.80	1.81	0.16	0.16	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	19.11	0.00	0.00	1.36	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.78	8.29	0.30	0.45	0.30	0.30	0.00	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	86.80	15.54	1.61	2.68	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	81.05	13.23	3.02	1.89	2.08	0.38	0.38	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	87.40	17.37	0.27	2.41	1.34	0.00	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	89.74	12.68	2.93	2.93	1.95	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	81.27	12.77	3.81	1.82	1.16	0.50	0.83	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	68.44	14.41	1.20	3.60	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	92.04	21.24	3.54	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	87.14	14.75	4.12	2.74	0.86	0.51	0.34	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	80.10	14.08	1.94	4.37	0.49	0.49	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	99.04	14.80	4.17	2.28	0.76	0.38	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	58.15	16.96	0.00	2.42	1.21	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	71.82	10.83	2.85	3.99	1.71	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	73.32	13.68	4.28	2.14	0.43	0.21	0.21	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	64.52	11.10	0.26	1.29	0.26	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	85.40	14.08	1.88	1.88	0.94	0.00	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	82.32	12.54	2.89	0.96	2.25	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	60.64	9.27	2.14	0.71	0.00	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	70.78	12.87	2.34	1.75	1.75	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	75.87	16.56	1.81	2.41	0.60	0.60	0.90	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	55.84	10.69	2.38	0.00	1.19	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	76.79	16.78	1.53	4.58	0.51	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	73.86	15.03	3.82	1.27	1.53	0.51	0.25	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	55.91	8.90	0.64	1.91	0.00	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	76.81	17.69	2.16	3.02	2.16	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	78.75	11.64	3.81	2.75	0.64	0.00	0.85	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	45.82	8.70	1.45	1.74	0.58	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	80.30	22.67	0.94	0.94	2.83	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	73.07	14.58	1.86	2.88	1.36	0.00	0.00	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	9.27	2.32	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	95.07	29.58	2.11	0.00	0.00	2.11	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	76.33	13.72	1.29	1.72	1.29	0.43	0.64	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.76	12.63	0.60	0.60	0.00	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	69.98	13.85	0.00	0.73	1.46	0.00	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	82.30	14.71	4.60	2.76	1.38	0.92	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	99.46	22.95	0.00	2.55	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	40.42	11.19	0.76	0.51	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	96.41	15.69	3.10	3.30	0.62	0.41	0.00	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	55.69	10.71	0.31	0.92	0.92	0.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	83.65	13.38	1.91	0.96	0.96	0.00	0.48	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	78.72	12.64	2.22	1.33	1.55	0.44	0.67	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	47.30	12.21	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	82.53	10.52	1.66	0.55	1.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	69.38	9.53	3.71	3.18	1.32	0.26	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	60.33	13.08	0.73	0.36	0.00	0.00	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	70.01	28.98	1.47	1.97	1.60	0.98	0.74	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	60.25	20.03	2.05	2.40	0.86	0.86	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	28.11	7.97	0.63	0.63	0.21	0.42	0.63	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	124.44	43.22	4.53	4.88	4.88	1.39	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	238.13	63.74	13.75	8.09	6.15	3.40	2.59	0.49	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	168.10	40.87	6.86	6.12	3.73	2.68	2.83	0.15	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	226.05	75.12	12.96	7.57	3.33	2.98	3.67	1.72	3.67
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	256.83	96.34	15.03	8.52	4.64	3.13	3.51	2.13	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	244.32	98.43	15.59	8.65	3.41	4.44	3.87	1.82	4.89
Basophils, donor1	12241-129G9	37.40	10.98	2.35	0.00	0.26	0.26	0.26	0.00	0.26
Basophils, donor2	12242-129H1	81.18	22.73	1.80	1.08	0.00	3.97	0.00	0.00	0.00
Basophils, donor3	12243-129H2	30.58	6.61	1.76	0.88	0.59	0.59	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	25.66	6.47	0.43	1.29	0.43	0.22	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	16.92	3.20	0.00	0.91	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	28.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	69.67	16.95	2.51	2.51	1.26	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	80.89	18.72	2.29	2.08	1.25	0.62	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	62.87	11.05	1.38	1.15	0.92	0.23	0.00	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	78.64	13.86	3.24	1.62	0.72	0.36	0.18	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	144.90	35.86	11.03	6.08	3.50	4.95	1.55	1.75	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	158.61	43.09	7.69	6.29	1.40	2.56	2.33	0.70	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	93.05	23.34	7.35	1.28	2.24	2.56	0.32	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	41.37	0.00	10.34	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	48.47	8.45	2.82	0.00	0.56	2.82	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	61.06	10.95	2.41	0.37	1.30	1.67	0.37	0.93	0.19
CD14+ Monocytes, donor3	11381-118B4	58.40	9.22	3.07	0.66	0.88	2.20	0.22	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	76.42	8.77	3.11	1.98	2.55	0.28	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	88.32	12.89	2.27	1.90	0.38	1.14	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	106.18	15.45	6.57	2.96	3.29	0.33	0.99	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	82.83	12.29	3.04	1.16	1.45	0.14	0.29	0.72	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	56.43	14.18	1.51	0.91	0.91	0.30	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	84.10	14.92	4.03	2.84	2.13	0.71	0.24	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	75.50	12.55	1.84	0.84	0.84	0.17	0.17	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	58.24	11.04	2.21	0.83	1.10	0.28	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.49	9.92	2.73	1.24	0.99	0.50	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	59.33	7.24	1.57	0.59	0.39	0.39	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	56.09	8.72	1.96	0.71	1.60	0.71	0.71	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	53.97	8.92	2.18	1.74	0.65	0.65	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	47.29	7.26	0.70	0.23	0.94	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	43.83	5.28	4.22	0.53	1.06	0.53	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	3.33	1.11	1.11	2.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	63.07	10.71	2.08	1.04	0.89	0.15	0.30	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	46.49	9.78	2.00	0.20	1.00	0.00	0.40	1.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	48.72	8.12	1.25	1.67	1.04	0.00	0.42	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	65.43	9.38	2.97	1.37	1.37	0.23	0.69	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	51.12	11.08	0.90	1.13	1.81	0.45	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.65	10.04	2.18	0.87	1.31	1.31	1.31	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	81.50	14.26	2.42	1.61	0.00	0.00	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	62.46	9.25	2.27	0.70	1.57	0.17	0.87	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	72.38	13.47	2.95	1.68	0.00	0.84	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	69.99	11.39	2.76	1.10	0.73	0.37	0.37	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	73.62	13.74	1.76	0.70	0.70	1.41	1.06	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	70.20	18.43	4.83	0.88	2.19	0.88	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	57.37	7.50	2.09	0.87	0.35	0.17	0.17	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	44.60	8.92	3.72	1.12	0.37	0.37	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	53.03	7.98	2.59	0.86	0.43	0.00	0.65	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	97.05	14.33	2.87	1.23	0.82	0.41	1.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.47	9.74	0.93	0.93	0.70	0.70	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	49.88	8.35	2.32	0.70	0.70	0.23	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	44.03	6.76	2.40	1.31	0.65	0.22	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	41.12	6.01	0.92	0.00	0.46	0.00	0.00	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	30.76	2.60	1.52	0.65	0.87	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	79.42	9.81	1.09	0.93	1.09	0.00	0.16	1.25	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	51.00	6.99	0.87	0.52	1.05	0.17	0.35	1.57	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	117.06	19.84	2.23	1.78	1.34	0.22	0.45	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	48.23	9.44	2.30	0.51	0.77	0.00	0.00	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	54.01	10.32	1.98	0.44	1.32	0.00	0.22	1.54	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	52.00	10.11	1.68	0.84	1.68	0.21	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	34.55	4.06	2.03	0.00	0.00	2.03	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	97.63	26.44	2.03	1.36	0.68	1.36	0.68	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	99.42	29.00	1.04	1.04	2.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	105.01	35.18	2.13	2.13	0.53	0.53	0.00	4.26	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	101.32	35.38	3.75	5.36	0.54	2.14	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	87.04	28.08	0.70	2.11	0.70	3.51	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	91.77	24.31	0.78	2.35	0.78	3.92	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	92.28	35.59	1.32	1.32	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	130.68	45.20	0.00	4.11	0.82	6.58	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	92.85	33.37	1.45	0.73	1.45	5.80	0.00	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	107.53	37.36	1.51	2.02	1.01	6.06	1.01	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	142.63	49.29	4.85	4.44	0.81	3.64	1.62	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	99.47	29.96	2.00	1.60	2.00	3.20	0.40	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	64.26	18.07	0.00	0.00	3.01	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	89.33	17.98	2.25	1.69	0.56	1.12	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	85.30	24.05	7.14	3.38	1.88	1.50	0.38	0.75	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	106.43	24.58	9.24	2.71	1.80	1.35	0.68	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	139.25	30.71	3.93	3.21	2.14	32.14	1.43	2.50	1.79
CD4+ T Cells, donor2	11306-117C1	108.39	26.94	2.45	0.61	2.45	8.57	0.00	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	88.14	24.70	3.35	0.61	1.83	9.76	0.91	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	125.07	34.97	1.28	3.57	1.79	3.83	0.77	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	114.54	24.93	1.80	2.92	1.80	2.02	0.22	0.90	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	123.32	33.35	1.72	4.02	0.86	4.02	0.57	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	67.80	27.50	2.37	2.37	0.47	13.27	1.90	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	80.06	23.18	0.70	4.21	1.40	8.43	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	29.67	3.30	0.00	3.30	19.78	3.30	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	103.62	20.38	1.88	2.31	1.88	2.46	1.01	0.43	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	106.42	23.56	2.71	4.24	1.69	4.91	1.02	0.51	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	98.98	17.25	2.26	1.77	0.97	3.87	0.48	0.81	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	66.80	17.48	2.24	2.69	2.24	10.76	0.90	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	76.52	23.76	0.35	1.05	3.14	10.13	1.05	1.75	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	85.80	34.76	2.20	2.64	1.76	9.68	0.44	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	118.48	30.78	0.84	3.79	0.84	2.53	1.26	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	92.67	15.79	2.08	2.08	1.25	2.70	0.42	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.85	17.04	0.67	0.67	0.33	1.00	0.33	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	88.38	32.36	1.36	1.90	1.90	25.83	1.09	1.09	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	116.84	31.09	0.54	2.68	2.14	27.33	1.61	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	84.28	30.48	3.59	1.79	3.59	23.31	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	170.59	31.89	1.67	4.45	2.04	4.26	1.30	1.67	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	106.14	21.23	2.17	3.90	1.52	4.55	0.65	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	108.44	23.96	1.47	2.73	1.68	4.83	0.63	1.26	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	71.29	21.24	0.00	2.02	1.52	9.10	0.51	0.51	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	74.09	14.30	1.73	1.30	1.30	9.96	1.30	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	91.96	24.84	1.31	3.49	3.05	15.69	0.87	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	131.64	37.61	6.43	4.45	1.48	9.90	0.49	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	108.01	28.62	1.85	2.77	3.69	7.39	2.77	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	101.90	27.92	0.00	0.00	2.79	5.58	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	168.93	51.51	2.77	4.15	3.05	13.29	1.11	1.94	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	159.50	55.21	1.96	3.93	2.45	15.71	2.21	0.00	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	115.50	46.20	0.00	4.62	0.00	10.78	3.08	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	130.71	39.75	2.15	3.94	0.72	7.88	1.07	0.72	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	128.80	23.54	1.38	2.77	1.38	1.38	4.15	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	99.53	21.94	1.64	2.95	1.64	10.15	1.96	1.31	0.65
CD8+ T Cells, donor2	11307-117C2	92.36	24.03	3.38	2.25	1.50	7.13	2.25	2.25	1.13
CD8+ T Cells, donor3	11383-118B6	97.71	28.53	6.31	1.77	1.77	13.38	2.52	0.00	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	134.88	41.75	2.98	11.01	2.75	1.61	1.15	0.69	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	148.58	48.41	2.64	11.50	2.16	1.44	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	161.42	48.15	1.92	9.30	2.19	1.37	0.82	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	137.80	42.93	5.40	7.51	4.20	1.20	0.60	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	145.19	44.16	2.64	9.84	2.88	3.36	0.96	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	150.76	46.61	2.73	5.68	1.59	1.36	2.05	0.68	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	164.70	51.06	4.56	12.17	2.61	1.96	1.09	0.00	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	178.98	52.90	2.37	8.95	3.16	2.37	0.79	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	186.21	55.35	2.11	8.68	3.99	2.35	2.35	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	153.66	48.00	3.62	9.66	3.02	1.21	1.81	0.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	170.24	56.94	1.45	5.52	3.20	2.32	1.16	0.00	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	139.88	45.29	2.93	11.46	2.93	4.00	2.66	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	159.34	41.15	1.31	9.19	3.06	3.50	2.19	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	153.02	51.46	0.46	5.92	0.46	2.28	0.91	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	234.20	73.10	0.75	8.20	2.98	3.73	2.98	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	133.26	41.78	3.24	10.08	2.52	0.72	1.08	1.44	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	124.30	37.98	2.01	8.34	2.59	1.44	2.01	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	153.20	50.44	2.36	7.54	2.12	2.12	0.71	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	153.70	44.68	3.80	9.51	3.17	3.49	2.22	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	155.93	51.98	3.38	11.99	2.46	2.77	2.77	1.54	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	150.03	52.58	4.17	12.82	1.92	2.56	2.89	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	143.81	39.01	3.44	7.27	0.38	2.68	1.53	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	139.12	40.20	0.79	7.88	2.36	2.36	1.58	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	134.64	65.81	1.51	6.05	1.51	1.51	2.27	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	99.57	27.30	4.01	4.01	0.80	3.21	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	104.21	39.17	2.10	2.10	0.00	3.50	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	117.20	35.06	3.01	11.02	0.00	3.01	1.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	202.88	42.04	0.00	7.31	1.83	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	85.97	14.33	7.91	3.95	1.98	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	98.71	17.36	11.37	3.58	2.63	1.05	0.84	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	95.33	19.76	4.85	3.12	2.43	0.00	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	57.57	12.08	1.07	1.42	1.42	0.00	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	77.60	11.83	2.73	2.96	0.91	0.68	0.46	0.11	0.23
Chondrocyte - re diff, donor2	11339-117F7	115.49	21.49	5.37	3.58	1.79	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	55.40	7.28	1.62	1.21	1.21	0.00	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	158.71	39.36	5.28	5.05	1.61	1.61	0.80	0.46	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	131.04	31.21	6.20	3.42	1.92	1.28	0.64	1.28	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	124.34	28.94	6.90	5.58	1.68	0.71	1.06	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	112.52	30.44	3.21	6.79	3.39	0.92	9.45	0.37	1.47
Corneal Epithelial Cells, donor1	11526-119I5	17.57	5.27	0.00	1.10	0.44	0.66	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	51.19	21.61	0.00	0.00	3.41	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	48.57	13.04	2.56	2.05	2.05	0.51	0.51	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	82.55	18.16	2.64	3.14	0.99	0.17	0.83	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	72.23	13.56	3.47	2.52	1.26	0.63	0.95	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	62.11	24.15	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	53.13	11.77	3.89	1.51	1.51	0.22	1.08	0.11	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	45.78	12.98	2.05	1.02	1.02	16.74	0.68	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	56.15	9.14	0.00	0.65	0.00	11.75	1.96	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	39.20	10.65	1.45	0.48	0.97	14.03	0.00	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	96.73	15.51	6.34	3.17	3.17	0.17	0.83	0.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	68.65	11.74	3.52	2.93	2.93	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	109.44	25.73	2.55	4.24	1.98	1.98	1.98	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	114.42	23.20	7.08	3.15	1.97	1.18	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	74.75	13.38	6.98	3.20	2.91	2.33	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	128.70	26.59	11.53	6.82	2.82	1.41	1.65	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	111.15	25.24	8.59	4.91	2.45	1.40	1.05	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	92.65	23.72	1.33	1.11	0.89	0.66	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	97.97	29.21	4.26	3.04	0.91	1.22	2.43	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	120.09	31.57	7.05	2.82	3.10	0.85	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	52.59	7.43	2.08	0.59	0.59	0.59	0.30	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	55.71	9.37	9.37	2.08	2.60	0.52	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	50.76	9.50	3.69	1.99	1.42	0.43	0.00	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	165.65	35.61	8.00	4.40	3.60	1.60	0.40	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	48.22	13.63	3.14	1.57	1.57	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	248.87	53.67	9.82	6.96	5.34	2.48	1.62	0.50	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	249.85	46.06	12.60	6.95	4.13	1.52	2.17	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	339.64	77.43	16.61	7.57	4.64	2.08	2.81	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	67.11	17.06	5.69	1.14	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	73.34	22.35	2.79	2.10	2.10	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	96.09	15.54	8.01	2.98	2.51	0.47	0.47	0.00	0.31
Eosinophils, donor1	12244-129H3	121.98	15.25	0.00	0.00	0.00	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	262.39	33.01	8.25	1.65	1.65	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	235.41	32.10	7.13	14.27	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	24.19	6.84	0.24	0.49	0.00	0.24	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	107.97	16.42	3.28	3.69	1.23	0.00	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	58.14	9.09	2.30	2.19	0.66	0.44	0.55	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	85.05	15.17	2.06	4.23	0.76	0.98	0.65	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	139.84	21.83	7.76	4.24	2.79	1.21	1.21	0.24	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	204.02	42.72	9.42	6.14	3.55	1.36	0.82	0.68	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	116.44	18.35	5.38	3.27	3.38	0.32	0.63	0.32	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	211.85	41.89	10.01	6.85	5.01	2.90	1.32	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	146.83	26.24	7.97	4.98	3.99	1.33	1.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	145.61	24.95	14.52	4.08	1.81	2.27	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	69.73	14.40	8.34	1.52	0.76	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	58.04	12.78	3.31	2.52	1.58	0.47	0.32	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	174.59	34.25	8.79	6.06	6.06	0.61	2.42	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	125.89	24.24	7.99	3.68	2.41	0.89	0.89	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	139.47	27.89	7.88	4.24	3.18	1.82	1.06	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	77.04	19.29	1.88	1.74	1.61	0.80	0.94	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	100.52	17.26	1.29	4.75	1.73	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	99.61	39.55	11.72	0.00	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	95.25	28.14	2.54	3.92	1.61	1.15	0.69	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	140.26	20.69	3.22	3.56	2.04	0.51	0.34	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	119.03	19.72	9.63	6.34	1.88	0.70	0.70	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	76.41	25.94	4.72	4.72	3.30	1.89	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	91.63	13.06	4.11	2.54	1.69	0.60	0.00	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	205.40	55.62	10.06	5.65	5.43	2.26	0.79	0.34	0.23
Fibroblast - Dermal, donor5	11454-119A5	241.97	70.30	10.64	9.59	7.85	4.19	2.97	0.70	0.52
Fibroblast - Dermal, donor6	11458-119A9	234.86	71.79	10.23	6.98	6.17	4.87	2.27	0.49	0.16
Fibroblast - Gingival, donor1	11237-116D4	172.62	28.32	3.54	3.54	2.92	0.21	0.42	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	175.80	33.27	5.76	7.07	3.41	0.79	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	162.88	37.43	8.83	5.40	2.24	1.19	1.32	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	215.51	33.84	6.19	4.74	1.55	0.77	0.48	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	127.78	24.93	7.27	3.12	3.12	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	126.69	19.38	3.70	5.64	3.17	0.18	0.18	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	252.24	54.41	10.60	8.89	5.30	4.05	2.03	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	226.51	45.57	5.54	7.84	3.52	1.22	1.35	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	393.81	93.87	12.70	14.82	7.06	5.29	2.82	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	207.96	50.89	2.78	6.00	1.46	0.44	1.02	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	240.53	46.63	6.68	7.09	3.00	0.95	1.50	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	368.90	76.13	10.31	10.75	4.72	4.28	4.17	0.44	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	153.93	22.60	2.20	3.96	1.91	0.00	0.59	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	42.14	10.87	5.44	1.36	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	141.75	37.30	4.48	7.46	2.98	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	97.08	19.20	8.44	3.38	1.90	1.48	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	94.96	44.15	0.83	2.50	0.83	0.00	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	54.55	19.58	2.80	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.79	3.64	0.56	0.00	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	138.84	52.37	2.84	3.65	2.84	1.62	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	19.97	0.00	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	178.69	17.87	0.00	0.00	0.00	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	168.37	47.52	7.95	5.82	2.72	2.91	1.94	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	332.79	92.22	13.04	10.77	4.85	3.79	2.73	0.61	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	262.54	66.40	11.63	9.49	4.28	3.67	2.75	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	210.27	39.69	12.98	6.87	6.87	1.14	1.91	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	127.71	19.17	9.99	4.86	4.05	0.54	0.81	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	133.95	21.69	4.29	4.75	3.25	0.46	0.70	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	102.24	18.13	9.17	4.42	2.21	1.44	1.11	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	96.31	31.49	2.03	2.24	1.63	0.41	0.61	0.61	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	78.18	19.38	1.34	0.67	2.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	90.54	15.42	4.35	5.54	1.98	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	343.71	69.46	14.49	14.09	7.34	2.78	0.99	1.19	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	83.13	13.50	3.02	2.66	0.71	0.36	0.53	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	121.21	23.85	5.12	4.93	2.76	0.20	0.59	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	234.67	44.53	12.94	9.93	6.02	1.20	1.20	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	159.88	33.90	6.26	4.64	4.32	1.08	1.40	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	252.06	41.00	8.35	7.59	5.31	1.01	0.51	1.27	0.00
Fibroblast - skin normal, donor1	11553-120C5	94.18	15.59	4.10	3.61	1.80	0.33	0.49	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	221.36	45.92	12.83	7.62	4.41	1.80	1.80	0.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	164.46	29.33	8.94	4.92	3.21	0.40	1.11	0.40	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	318.56	58.33	11.49	9.97	5.74	2.12	1.21	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	134.62	19.88	2.90	5.38	2.32	0.58	0.75	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	138.30	25.47	4.10	2.22	2.91	0.68	0.68	0.68	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	202.64	47.95	6.90	8.87	5.25	1.64	1.31	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	147.85	31.53	6.07	4.15	4.58	1.38	0.85	0.75	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	111.84	21.59	6.75	5.57	3.54	1.18	1.35	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	102.25	15.84	1.88	2.98	0.94	0.47	0.63	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	709.11	110.80	44.32	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	79.31	7.84	0.00	2.61	2.61	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	96.91	22.19	2.25	3.12	1.39	0.00	0.69	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	113.20	31.75	5.73	4.16	2.60	1.56	1.30	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	143.34	45.48	7.41	4.60	3.07	1.79	3.07	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	140.10	57.42	6.12	6.89	3.06	9.19	4.59	0.00	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	123.15	66.36	2.55	4.47	1.28	12.76	4.47	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	200.26	104.69	7.42	5.13	3.14	15.69	9.98	0.57	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	236.05	76.38	14.34	8.55	5.52	6.07	2.76	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	149.10	45.44	5.02	7.76	2.74	3.65	3.65	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	172.97	93.72	7.73	5.75	2.38	8.52	8.52	0.40	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	191.38	72.43	10.57	6.34	3.17	5.02	3.17	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	140.24	46.97	6.20	7.83	2.61	4.24	2.28	0.00	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	194.14	118.52	4.86	4.42	2.65	17.25	6.63	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	167.61	61.33	7.63	5.23	6.08	5.37	4.80	0.28	1.55
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	167.10	55.78	9.36	4.93	3.45	5.05	4.43	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	163.86	73.07	8.60	7.25	2.95	8.33	4.57	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	136.41	47.20	6.69	4.46	3.47	1.98	2.48	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	145.62	52.19	6.23	4.15	3.18	3.32	1.66	0.00	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	145.16	55.91	5.69	3.66	1.83	3.86	2.44	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	128.01	36.51	5.02	4.11	2.51	1.37	0.91	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	133.78	44.47	7.47	3.99	2.37	1.74	1.87	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	171.58	63.39	8.74	3.50	2.40	2.62	2.62	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	119.96	35.46	5.32	3.25	2.07	2.07	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	145.45	34.97	6.52	4.45	3.81	0.95	1.11	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	130.92	40.22	6.26	3.80	1.56	0.67	0.45	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	145.98	34.48	4.84	4.64	2.02	0.60	0.81	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	143.18	38.17	5.77	4.07	2.88	0.68	1.36	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	171.58	62.25	5.14	4.79	3.19	2.13	2.66	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	187.41	56.19	4.79	4.89	3.23	0.94	1.35	0.21	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	157.46	56.19	4.10	2.56	3.76	1.20	1.37	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	143.30	30.98	5.42	3.98	3.32	0.66	1.11	0.11	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	142.60	46.59	4.99	4.83	3.33	1.58	0.83	0.33	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	119.04	45.12	3.68	3.68	2.25	1.23	0.61	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	133.69	30.74	4.54	3.92	1.65	0.21	0.83	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	145.62	32.74	6.23	3.80	4.04	1.04	1.27	0.23	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	132.74	33.35	8.84	5.17	3.17	0.67	0.00	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	122.34	28.88	4.19	3.75	2.42	0.22	0.22	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	125.94	26.44	6.52	4.18	2.58	0.12	0.86	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	123.51	32.74	6.65	6.16	3.24	0.81	0.81	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	143.36	31.11	3.85	3.21	1.92	0.00	0.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	115.98	25.02	5.59	4.45	2.08	0.76	0.57	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	125.75	22.62	6.80	4.59	2.69	0.63	0.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	116.77	31.02	5.47	3.34	1.52	0.30	0.30	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	115.51	24.36	7.11	3.55	3.87	1.25	0.52	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	115.93	27.44	4.17	4.39	1.54	0.66	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	130.17	25.25	2.81	2.52	2.24	0.56	1.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	112.49	18.70	5.56	3.15	2.59	0.19	0.65	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	101.08	27.81	5.88	4.28	2.41	0.27	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	134.64	29.38	9.18	4.59	2.75	0.61	0.92	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	104.28	18.01	5.57	2.20	2.20	0.91	0.78	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	111.41	17.35	4.07	4.07	1.90	0.54	0.81	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	112.09	23.78	3.32	3.69	0.92	0.74	0.55	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	110.97	18.20	4.61	4.39	2.63	0.22	0.88	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	258.85	48.60	6.94	2.98	0.99	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	120.30	20.58	5.67	4.49	3.69	0.40	0.40	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	107.54	15.94	3.03	3.03	3.83	0.61	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	244.25	64.56	3.30	6.10	2.03	0.76	1.27	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	231.11	138.15	12.94	8.56	5.97	16.32	10.55	1.00	2.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	164.25	67.49	10.63	7.09	5.24	11.09	6.78	0.00	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	247.75	113.75	10.43	8.18	4.71	14.53	11.46	0.20	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	62.90	40.06	4.07	2.82	1.56	6.26	4.38	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	72.33	46.90	1.70	3.11	2.54	4.24	2.83	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	151.28	76.10	7.84	6.46	2.31	11.99	5.53	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	126.21	69.29	14.85	7.42	4.95	14.85	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	150.08	51.83	11.99	10.83	5.42	6.58	3.48	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	182.91	70.60	1.60	6.42	0.00	12.84	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	121.72	41.73	12.17	3.48	3.48	1.74	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	114.89	45.57	9.11	5.53	3.25	5.21	2.60	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	172.96	57.65	6.18	4.53	2.06	4.94	2.47	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	136.62	46.65	6.66	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	141.22	42.79	6.71	4.75	1.68	4.47	1.12	0.28	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	150.67	47.39	5.23	7.84	1.31	5.56	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	125.83	42.78	6.71	3.36	1.68	3.36	3.36	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	151.08	52.16	6.04	4.45	3.50	3.50	1.91	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	126.69	49.59	6.11	6.11	2.38	1.70	1.70	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	68.91	18.79	2.09	2.09	4.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	178.11	62.42	4.01	3.44	4.01	1.72	4.01	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	96.79	34.93	4.44	5.92	2.37	2.37	0.59	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	74.54	23.72	3.39	0.00	5.08	1.69	1.69	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	156.98	46.81	10.36	6.63	3.31	6.21	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	147.97	44.18	6.90	5.06	2.99	2.53	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	31.61	0.00	0.00	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	103.02	30.37	5.38	3.46	2.31	2.31	2.31	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	98.12	35.86	5.22	3.59	2.28	2.28	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	80.93	32.10	4.01	2.68	0.67	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	157.19	46.23	5.39	4.62	2.31	2.31	1.16	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	157.82	39.71	8.22	5.14	5.14	1.03	2.74	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	91.94	22.36	0.00	0.00	4.97	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	94.84	32.09	4.72	1.42	0.94	1.42	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	128.54	32.59	3.62	4.22	3.62	1.21	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	107.33	21.36	4.58	2.54	4.07	1.53	1.02	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	123.64	49.46	3.99	3.19	3.59	0.80	1.20	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	117.42	36.51	1.97	4.93	0.99	0.99	0.99	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	89.71	18.89	1.18	3.54	1.18	0.00	1.18	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	90.43	23.92	1.17	1.17	1.17	1.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	121.57	41.25	2.19	2.63	0.88	1.76	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	83.07	27.97	5.09	4.24	0.00	1.70	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	64.47	16.71	2.39	2.39	1.79	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	93.17	23.29	5.82	1.94	2.43	1.94	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	70.76	18.26	2.28	1.14	5.71	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	80.67	14.55	3.33	4.57	2.49	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	76.46	15.74	2.25	5.62	2.25	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	89.44	11.10	2.85	2.85	1.27	0.00	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	73.10	8.35	3.34	1.25	1.67	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	180.91	58.37	5.57	6.27	3.25	3.48	2.55	0.93	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	178.25	64.65	6.92	7.76	2.53	2.70	4.73	0.68	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	171.08	56.19	6.60	4.78	3.19	2.50	3.64	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	179.92	55.20	5.90	5.25	3.17	2.62	2.84	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	185.90	58.67	7.95	7.31	2.79	3.01	3.87	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	164.91	52.96	5.60	5.38	2.58	3.88	1.72	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	171.61	52.80	5.85	6.60	1.87	2.99	2.86	0.25	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	152.51	52.49	4.46	5.32	1.89	2.40	3.43	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	139.36	50.30	3.20	6.09	1.60	3.20	4.49	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	59.88	24.62	1.68	1.68	0.56	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.12	7.79	0.43	1.30	0.87	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	134.83	21.15	0.00	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	37.04	15.87	2.82	2.47	1.06	1.06	1.76	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	45.04	5.09	1.45	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	102.46	21.68	9.62	4.72	3.67	1.05	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	125.90	21.79	0.00	2.42	0.00	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	121.74	29.09	2.15	2.15	2.15	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	118.41	23.93	1.84	3.68	0.61	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	164.48	48.95	8.48	5.22	2.61	16.32	0.65	1.31	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	253.61	70.44	6.82	5.94	4.89	2.97	3.15	0.87	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	113.74	30.19	6.59	3.98	2.74	0.69	1.23	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	232.42	60.49	15.92	12.74	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	106.80	40.05	13.35	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	157.82	49.84	9.69	4.15	1.38	1.38	0.00	0.00	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	32.53	2.50	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	161.46	64.07	12.81	2.56	2.56	0.00	2.56	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	77.70	0.00	13.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	198.17	60.10	4.87	1.62	1.62	1.62	3.25	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	121.71	23.34	1.67	5.00	3.33	1.67	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	101.66	29.04	18.15	3.63	7.26	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	194.55	72.79	13.23	3.97	0.00	2.65	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	129.71	42.13	9.98	3.33	1.11	5.54	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	83.81	52.38	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	141.09	45.98	10.08	3.78	2.52	1.89	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	139.20	23.20	10.83	6.19	3.09	3.09	6.19	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	43.90	0.00	0.00	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	155.70	54.91	3.23	3.88	1.94	0.65	1.94	0.00	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	175.48	35.42	14.49	6.44	0.00	1.61	0.00	0.00	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	187.42	63.56	7.33	3.26	2.44	1.63	0.00	0.00	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	125.52	40.30	4.62	5.46	0.42	1.68	2.10	0.84	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	14.37	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	171.99	51.44	2.41	4.02	0.80	3.21	2.41	0.00	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	130.18	25.85	8.31	7.39	0.00	1.85	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	113.76	37.29	9.44	2.36	1.89	0.94	2.36	0.47	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	105.21	22.67	5.44	3.63	1.81	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	29.48	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	178.64	45.20	7.53	5.38	3.23	1.08	0.00	0.00	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	148.64	68.61	7.62	3.81	2.54	1.27	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	168.98	73.33	5.10	5.74	1.91	1.91	1.28	0.64	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	127.59	38.28	16.40	0.00	1.82	5.47	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	179.94	47.84	9.28	0.00	3.57	1.43	0.00	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	155.96	59.73	23.23	3.32	0.00	3.32	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	41.70	20.85	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	125.93	37.66	7.10	2.16	1.85	1.23	2.16	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	170.33	59.70	12.29	5.27	3.51	3.51	1.76	1.76	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	125.73	62.86	0.00	0.00	3.14	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	225.31	43.11	9.04	3.48	2.09	2.09	2.09	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	108.44	19.92	6.64	0.00	2.21	0.00	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	142.65	35.66	0.00	0.00	0.00	0.00	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	110.74	35.75	6.10	1.74	2.62	0.87	0.00	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	114.74	20.25	4.50	4.50	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	27.88	6.97	3.48	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	82.14	24.54	2.13	5.33	1.07	2.13	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	128.85	47.11	4.16	5.54	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	136.78	45.59	0.00	8.55	2.85	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	141.75	31.29	3.68	1.84	0.00	0.92	1.84	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	27.23	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	124.17	49.67	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	89.88	31.72	2.11	2.11	1.06	1.06	3.17	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	125.99	31.74	1.63	3.92	0.90	0.57	0.90	0.49	0.08
Keratinocyte - epidermal, donor2	11349-117G8	38.07	5.86	1.76	0.59	0.00	0.00	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	108.29	22.34	7.10	4.26	1.89	0.76	0.47	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	173.57	30.31	5.90	4.65	2.95	0.57	0.57	0.23	0.23
Keratocytes, donor1	11527-119I6	70.14	17.19	1.38	3.44	2.75	0.34	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	45.70	9.37	0.00	1.17	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	158.08	26.48	5.34	3.56	1.98	0.00	0.99	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	158.25	35.17	0.00	2.20	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	108.95	24.81	4.31	2.16	2.16	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	97.69	25.83	5.65	3.46	1.38	0.35	0.69	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	167.31	43.19	5.85	3.53	1.61	0.81	1.21	0.40	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	71.26	12.81	5.45	1.90	1.90	0.24	0.47	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	64.47	7.26	1.40	0.56	0.28	1.12	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	101.37	11.02	2.99	4.09	2.05	0.16	0.47	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	62.91	11.83	2.15	2.69	2.15	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	86.99	15.44	1.89	1.89	2.52	0.00	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	56.39	10.03	2.16	1.51	1.08	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	71.41	11.08	2.46	2.05	0.82	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	39.95	7.58	1.52	1.01	0.76	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	56.72	10.98	3.24	1.41	0.99	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	67.64	7.12	3.96	1.58	1.98	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	70.38	8.92	2.91	1.36	2.52	0.39	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	34.44	5.18	1.11	0.74	0.37	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	67.94	8.36	3.83	2.79	2.09	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	66.31	13.83	2.15	0.95	0.95	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	56.18	7.28	2.88	1.24	1.37	0.14	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	68.67	14.17	2.77	2.77	1.23	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	38.97	4.99	0.62	0.94	0.00	0.00	0.00	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	63.86	11.35	3.48	2.20	0.73	0.73	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	64.83	11.85	3.29	1.32	1.97	0.00	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	51.25	7.61	1.76	1.46	0.59	0.29	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.55	6.22	2.24	1.49	0.50	0.00	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	59.17	13.09	5.82	0.48	1.94	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	69.21	9.16	2.96	1.62	1.08	0.27	0.54	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	76.14	10.45	1.97	2.57	1.36	0.45	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.10	10.37	2.07	2.07	1.04	0.52	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	84.80	11.31	2.51	2.51	1.26	0.84	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	60.90	11.13	2.71	2.11	1.35	0.15	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	65.35	9.63	4.13	0.69	1.38	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	64.72	9.03	2.63	2.26	1.69	0.38	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.27	9.75	2.33	1.91	1.27	0.11	0.32	0.42	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	72.20	12.60	1.94	0.48	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	58.88	9.59	0.66	1.65	0.00	0.33	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	46.46	8.30	1.61	1.86	1.49	0.25	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	82.56	12.96	4.44	3.70	1.48	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	57.08	9.39	0.99	1.48	0.99	0.74	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	47.71	7.15	2.89	1.24	0.69	0.14	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	74.30	11.90	3.86	3.22	0.96	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	83.69	13.39	1.83	1.52	0.30	0.30	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	78.52	9.66	4.06	1.54	1.40	0.28	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	60.80	12.09	2.13	1.07	0.36	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	47.02	7.27	0.97	1.94	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	41.55	4.98	2.02	0.93	0.62	0.00	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	58.37	8.95	3.22	0.72	1.07	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	71.87	11.11	2.29	1.96	1.63	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	30.37	4.47	1.41	0.47	0.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	81.06	14.23	7.05	3.59	1.61	0.62	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.47	9.99	1.02	0.51	0.26	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	56.09	8.65	1.79	3.28	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	67.98	31.72	0.00	2.27	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	65.21	16.88	4.60	3.07	0.77	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	52.70	11.88	5.94	3.71	2.97	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	66.01	19.89	2.12	3.39	2.54	1.27	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	43.61	9.85	0.70	2.11	2.11	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	44.83	13.08	0.93	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	57.71	10.82	1.03	1.03	0.00	0.00	0.52	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	4.76	8.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.37	12.67	2.49	2.26	1.81	0.00	0.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	77.07	24.14	3.78	3.20	2.91	0.29	0.29	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	81.03	25.21	9.00	3.60	0.90	0.90	0.90	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	63.14	16.39	2.57	1.90	2.30	0.41	0.41	0.54	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	51.35	21.57	1.54	1.03	2.57	0.00	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	87.16	18.70	8.12	2.12	3.18	1.41	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	59.97	14.66	5.33	5.33	1.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	65.20	20.38	1.53	2.55	0.51	0.00	0.00	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	90.18	18.14	11.47	2.13	2.93	1.33	0.27	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	82.57	23.24	4.91	4.16	2.27	0.57	0.19	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.95	15.34	3.07	3.07	2.45	0.00	0.00	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	77.47	16.31	6.52	0.00	4.08	0.82	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	104.54	25.20	7.08	2.92	1.87	0.00	0.21	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	89.68	24.38	3.36	4.20	2.24	0.56	0.28	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	55.64	18.55	6.18	1.03	3.09	2.06	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	88.25	25.55	10.16	3.77	2.61	0.87	0.58	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	84.60	19.13	3.89	2.69	2.39	0.30	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	90.18	21.02	8.30	3.32	3.87	1.11	1.11	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	69.64	15.20	4.60	2.12	3.89	1.06	0.00	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	69.33	18.07	3.69	2.21	2.58	0.37	0.37	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	9.21	5.76	2.30	0.00	0.00	1.15	0.00	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	62.17	20.34	4.61	2.69	1.15	0.38	0.38	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	66.80	19.25	2.83	2.26	1.70	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	65.64	26.25	4.10	7.38	4.92	0.00	0.00	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	55.13	17.17	4.97	3.62	2.71	0.45	0.00	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	76.12	15.80	1.44	5.75	2.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	72.45	14.19	5.98	3.73	3.73	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.12	15.24	3.34	2.97	2.60	0.00	0.37	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	73.23	21.11	4.74	3.45	2.15	0.86	0.00	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	75.35	21.41	4.28	5.99	4.28	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	64.30	17.99	2.67	1.67	2.00	0.00	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	69.38	20.51	2.41	5.43	2.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	66.12	16.35	2.13	3.55	2.13	0.00	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	68.74	23.37	4.81	3.78	1.37	0.00	0.34	0.69	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	73.53	18.79	1.07	1.07	1.07	1.07	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	55.22	16.83	3.37	2.69	2.02	1.35	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	85.93	21.11	2.59	2.59	2.59	0.37	0.00	1.85	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	81.41	29.07	1.16	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	15.87	5.29	1.06	1.06	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	69.63	18.01	5.60	3.20	1.60	0.40	0.00	2.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	63.96	21.08	2.91	3.63	2.18	0.73	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	19.16	5.37	3.83	2.30	0.00	1.53	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	61.66	18.25	1.48	1.48	0.99	0.99	0.00	1.97	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	16.00	0.94	2.82	0.00	0.00	0.94	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	60.34	14.58	4.53	4.02	2.01	1.01	0.50	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	17.12	3.15	2.25	1.35	0.45	0.90	0.90	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	20.65	0.00	5.16	3.44	0.00	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	65.47	16.92	4.45	1.34	1.78	0.00	0.45	1.78	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	74.29	20.72	2.35	3.13	2.35	0.78	0.39	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	58.06	23.09	1.98	0.66	1.98	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	56.04	18.16	6.23	2.08	3.11	0.52	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	70.89	22.75	5.25	2.63	0.44	0.00	0.88	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	62.62	16.77	2.80	2.24	1.68	0.56	0.56	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	58.30	13.69	5.74	2.21	1.32	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.21	25.46	5.40	0.77	2.31	0.39	0.00	2.31	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	65.32	20.25	2.53	3.04	2.03	0.00	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	65.36	17.78	8.17	4.33	1.92	0.48	0.96	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	71.96	16.70	3.58	2.78	1.19	0.40	0.40	1.19	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	73.52	21.27	1.22	0.00	1.22	0.61	0.00	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	62.25	16.60	2.77	2.08	2.08	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	70.30	12.54	4.94	3.42	2.66	0.00	0.38	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	61.97	20.66	2.07	2.07	1.03	0.00	1.03	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	69.54	23.58	4.23	0.00	3.63	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	69.40	15.85	8.56	3.49	1.58	0.32	0.00	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	62.90	21.86	1.07	2.67	2.13	0.53	1.07	0.53	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	66.09	12.64	0.57	2.87	1.72	0.57	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	67.88	15.43	4.63	1.54	2.57	0.51	0.51	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	70.03	19.10	2.12	2.83	2.12	0.00	0.71	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.26	25.54	2.84	3.40	0.57	0.00	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	67.40	15.81	3.74	1.66	1.25	0.83	0.42	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	73.61	23.49	1.57	2.35	1.57	1.57	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	75.99	23.38	2.09	1.67	2.51	0.42	1.67	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	54.36	13.94	5.11	2.32	1.86	0.00	0.46	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	56.20	20.07	3.35	2.68	2.68	0.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.73	24.59	3.21	1.60	3.74	0.00	1.07	2.67	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	65.06	18.59	5.25	4.45	2.42	0.40	0.00	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	61.49	26.62	2.75	4.59	2.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	88.02	35.56	4.45	2.67	0.89	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	68.38	24.50	5.70	3.42	2.85	0.00	1.14	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	54.45	18.41	0.00	2.30	1.53	0.00	0.77	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	112.17	36.11	2.74	3.28	4.38	2.19	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	64.14	22.27	6.68	4.01	2.67	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	64.47	23.66	3.64	2.60	1.56	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	102.78	33.16	1.33	4.64	2.65	0.00	2.65	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	35.34	8.31	2.08	2.08	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	65.87	7.98	3.65	2.05	2.96	0.23	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	59.09	13.03	5.14	2.75	2.39	0.92	0.55	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	84.15	14.55	8.78	4.85	4.46	0.79	0.52	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	60.54	19.12	2.12	2.12	0.00	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	98.08	23.61	2.85	3.96	1.27	1.11	1.27	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	118.28	36.41	3.47	4.59	2.08	0.42	2.22	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	194.01	30.59	8.07	5.78	2.69	1.89	1.00	0.50	0.20
Mammary Epithelial Cell, donor2	11350-117G9	120.16	28.95	9.84	4.63	2.32	2.03	1.45	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	68.09	17.46	5.74	2.24	1.00	0.75	1.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	298.29	72.54	10.85	7.46	4.75	0.68	0.00	0.68	1.36
Mast cell, donor1	11563-120D6	104.25	20.22	4.33	3.89	3.68	0.22	0.32	0.43	0.43
Mast cell, donor2	11565-120D8	86.77	24.96	4.16	3.57	2.97	1.19	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	71.14	21.39	2.93	2.03	4.28	0.00	0.23	0.00	0.23
Mast cell, donor4	11567-120E1	114.88	29.43	3.72	2.84	5.67	0.18	0.18	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	83.61	24.73	1.89	3.11	1.55	0.67	0.55	0.55	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	108.56	41.44	1.17	4.67	2.33	0.00	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	74.57	16.63	2.06	2.41	1.15	0.11	0.34	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	113.47	36.32	0.50	2.01	3.51	0.17	0.50	0.17	1.00
Melanocyte - dark, donor1	11502-119F8	89.15	16.12	10.94	2.29	2.09	0.40	0.60	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	87.91	13.15	4.15	2.42	2.42	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	126.26	20.86	15.36	5.22	2.46	1.38	0.72	0.43	0.00
Melanocyte - light, donor1	11274-116H5	67.94	12.46	1.18	1.88	1.65	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	48.46	8.19	1.36	0.68	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	45.10	11.27	3.47	0.87	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	133.07	22.49	10.31	3.02	3.44	0.83	1.87	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	101.12	24.74	6.45	5.38	2.69	0.81	1.08	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	130.45	22.50	5.36	5.09	2.14	0.54	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	144.90	46.40	4.84	4.09	4.09	2.48	1.98	0.50	0.37
Meningeal Cells, donor2	11573-120E7	157.57	65.58	3.96	3.52	3.08	4.40	3.08	0.00	0.44
Meningeal Cells, donor3	11654-122E7	223.64	55.18	9.78	8.48	5.05	3.83	1.55	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	117.20	27.66	8.84	5.42	2.57	2.00	0.86	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	98.72	19.42	2.52	2.62	0.70	0.60	0.91	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	1.31	2.63	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	13.08	2.62	1.31	0.00	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	116.97	35.16	10.76	5.74	2.15	2.15	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	73.70	16.94	2.33	3.18	1.27	0.21	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	95.50	21.11	3.02	3.52	1.01	0.50	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	52.30	21.10	1.76	3.30	0.88	0.88	0.88	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	97.17	27.76	1.46	3.65	2.19	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	77.54	22.51	1.43	1.84	1.64	1.64	0.82	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	118.56	23.27	4.29	3.32	2.77	0.42	0.28	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.76	7.43	1.12	1.12	0.00	0.37	0.74	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	125.26	19.47	2.11	4.34	2.76	0.26	0.39	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.63	3.86	0.30	0.30	0.30	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	9.34	0.00	0.00	2.34	0.00	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	64.68	16.01	2.56	1.28	0.64	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	144.97	26.23	9.22	4.61	2.84	2.48	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	99.45	10.32	4.69	2.50	1.56	0.31	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	90.71	26.12	9.43	4.35	2.18	2.18	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	89.89	19.36	2.92	2.39	1.33	0.00	0.80	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	91.59	21.02	5.51	2.00	2.00	0.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	85.06	13.59	3.04	2.89	1.88	0.65	0.43	0.07	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	191.75	75.62	8.10	2.70	2.70	0.00	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	101.96	24.13	7.63	2.71	2.96	0.25	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	83.33	16.78	3.83	2.06	2.65	1.18	0.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	110.63	20.74	0.00	3.46	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	57.65	8.68	3.72	2.48	1.55	0.00	0.62	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	63.06	13.69	2.90	1.04	1.66	0.21	0.41	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	127.38	18.53	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	71.83	11.26	6.01	2.50	3.25	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	113.11	28.39	3.26	2.33	1.86	0.93	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	233.59	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	78.24	15.24	6.10	3.05	2.85	0.41	1.22	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	73.25	17.42	3.56	1.98	1.19	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	179.58	25.65	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	54.87	12.39	2.65	2.65	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	59.27	12.92	3.42	1.52	1.52	1.14	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	111.85	17.11	0.00	2.63	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	60.91	9.13	4.67	1.49	2.12	0.42	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	104.97	27.62	0.92	0.92	0.00	2.76	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	86.73	18.48	3.58	2.68	1.49	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	216.29	45.27	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	101.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	59.21	11.29	3.01	2.01	1.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	79.38	19.01	3.09	2.14	1.19	1.19	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	87.91	18.80	2.76	3.32	0.55	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	63.32	14.97	5.30	3.68	1.61	1.61	1.38	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	86.66	19.56	4.21	2.52	2.10	1.26	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	93.76	20.79	6.93	2.65	1.22	0.61	1.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	59.43	11.16	5.15	2.79	1.72	1.29	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	116.04	28.90	2.89	2.67	1.33	1.56	1.11	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	278.60	82.55	0.00	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	72.49	17.30	4.60	3.07	1.10	1.75	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	162.23	47.65	4.56	7.10	2.53	2.03	2.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	182.27	29.83	3.31	0.00	3.31	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	124.21	32.89	6.79	4.89	4.35	1.36	1.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	129.10	36.47	2.94	4.71	2.94	2.94	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	175.54	68.69	2.18	1.09	2.18	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	61.03	9.13	4.32	3.84	2.88	0.96	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	103.66	27.62	4.40	2.80	0.40	2.40	0.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	266.02	49.36	6.86	6.86	1.37	1.37	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	80.59	17.52	7.01	5.51	3.00	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	267.04	75.42	2.04	10.19	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	102.47	24.96	4.38	3.50	3.94	1.75	1.31	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	210.80	48.56	9.93	12.14	0.00	4.41	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	304.18	66.60	7.68	10.89	1.92	1.28	1.92	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	108.84	29.01	8.93	5.21	4.21	0.74	0.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	152.40	43.15	7.65	3.48	0.70	0.70	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	428.72	117.12	13.26	19.89	0.00	0.00	4.42	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	94.36	20.85	10.26	6.15	0.68	1.71	0.34	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	192.55	45.95	12.25	9.19	4.38	3.06	3.94	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	333.44	64.63	7.81	8.88	3.20	5.33	3.20	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	99.60	29.18	7.57	3.37	3.65	1.40	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	119.29	26.60	12.47	6.65	4.16	5.40	2.08	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	340.32	78.09	10.49	6.41	3.50	3.50	2.91	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	137.86	31.98	10.56	5.13	4.22	1.21	1.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	87.23	27.13	11.69	2.50	4.59	1.67	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	462.00	72.19	14.44	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	167.16	37.87	9.24	7.39	3.69	0.92	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	171.30	41.55	7.40	10.24	5.12	5.12	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	189.03	38.97	11.61	5.53	4.28	2.76	3.32	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	89.92	26.43	11.40	5.18	3.11	1.55	1.04	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	168.16	51.91	11.15	7.72	4.72	2.57	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	247.09	50.82	8.89	5.72	2.54	3.81	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	148.12	38.43	9.07	3.20	2.94	2.94	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	91.59	23.95	12.57	5.39	3.89	2.39	1.50	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	139.14	25.71	10.45	3.39	2.54	1.41	0.99	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	85.68	27.07	3.82	2.55	3.19	0.64	1.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	129.58	32.73	12.83	7.30	4.20	5.09	1.11	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	198.70	43.23	9.10	6.83	2.28	2.65	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	109.66	29.83	6.82	6.82	2.56	0.85	1.99	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	93.90	26.06	9.34	3.69	2.70	1.97	2.46	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	184.42	31.93	13.03	6.52	2.61	2.61	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	94.09	22.05	9.11	4.41	2.35	1.47	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	103.80	23.64	9.80	3.46	3.17	2.59	2.59	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	119.52	26.79	5.77	4.95	2.89	0.00	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	69.38	12.80	8.64	0.89	2.38	0.00	1.49	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	58.16	10.51	3.29	1.64	1.97	0.00	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	3.16	4.21	1.05	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.42	6.72	1.19	0.99	0.59	0.20	0.20	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	58.67	10.24	1.86	1.86	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	38.68	4.51	2.25	0.75	1.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.76	4.79	1.60	1.07	0.80	0.00	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.57	6.45	3.28	1.58	1.47	0.11	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	8.10	2.21	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	48.73	7.33	2.56	2.56	0.37	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	4.67	0.00	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	5.88	3.21	1.07	0.53	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	41.41	6.06	3.03	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.90	5.90	1.69	1.26	0.84	0.84	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	13.62	0.00	0.00	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	13.99	3.81	2.54	0.00	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	23.49	4.86	0.81	1.62	0.81	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	0.00	0.00	1.51	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	154.17	28.55	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	22.84	22.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	19.01	9.50	4.75	4.75	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	95.44	21.11	7.32	4.96	2.80	0.43	0.65	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	98.77	15.16	3.66	5.23	0.52	0.00	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	114.14	36.04	1.33	3.34	0.00	3.34	2.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	68.87	12.52	0.83	1.67	1.67	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	370.78	64.46	9.89	12.93	2.47	1.52	2.09	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	323.96	68.62	3.19	11.17	1.60	3.19	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	46.24	12.24	0.68	1.36	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	722.19	88.21	5.51	7.35	1.84	0.00	7.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	43.53	8.37	1.26	1.26	0.42	0.84	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	65.08	14.18	2.32	3.02	0.93	1.16	0.46	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	86.47	18.38	1.08	1.89	0.81	1.08	0.81	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	108.06	25.02	2.52	3.15	0.21	0.84	0.84	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1169.15	89.08	89.08	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	72.96	15.88	0.00	0.99	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	74.43	9.20	0.54	2.17	0.81	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	35.14	6.57	0.45	1.36	0.45	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	84.43	14.70	1.14	2.94	0.82	0.16	0.49	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	110.63	24.79	2.37	3.10	1.64	0.36	0.91	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	62.06	14.32	0.53	2.12	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	53.43	9.60	1.20	0.60	0.00	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	471.59	77.78	3.94	10.17	1.31	0.98	0.98	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	44.40	9.59	0.65	0.65	0.33	0.33	0.33	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	174.44	40.74	3.35	3.53	1.23	0.53	0.88	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.01	9.85	0.00	3.52	0.00	0.00	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	44.13	8.27	0.92	2.30	0.00	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	45.95	12.21	0.32	0.64	0.64	1.61	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	361.44	49.66	5.86	8.62	1.72	0.34	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2553.73	257.90	65.74	45.51	17.70	7.59	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	156.39	36.09	2.90	1.56	0.67	0.45	1.34	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	45.73	9.74	0.00	2.12	0.42	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	84.97	18.51	0.95	2.37	1.19	0.24	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	44.64	12.88	0.43	0.43	0.43	0.43	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1498.61	63.19	45.14	18.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	76.97	17.33	1.00	1.33	2.33	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	156.45	49.59	0.45	2.71	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	32.14	14.68	0.40	1.19	0.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	48.29	15.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	34.81	10.22	1.51	0.76	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	79.19	21.18	0.65	3.58	0.98	0.98	0.65	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	92.39	29.20	0.00	2.61	0.87	0.00	0.44	0.00	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	139.76	37.09	0.90	2.71	1.81	0.45	2.26	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	52.03	10.58	0.00	0.00	0.00	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	41.22	11.97	0.66	2.66	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	39.68	11.91	0.50	1.98	0.99	0.00	0.50	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	47.09	19.52	0.38	1.91	0.00	0.00	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.77	10.59	1.51	0.91	0.00	0.91	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	124.44	37.13	1.33	1.55	0.66	0.66	1.11	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	36.59	12.20	0.68	1.36	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1011.69	81.75	10.22	25.55	10.22	5.11	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	5.49	0.00	0.00	1.83	0.61	1.83	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	46.27	9.76	0.94	1.26	0.00	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	62.95	14.53	0.61	0.30	0.61	1.21	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	31.65	8.70	0.00	1.58	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	399.04	68.02	4.53	19.27	0.00	0.00	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	642.35	40.46	5.06	25.29	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	85.10	20.87	3.48	3.23	1.61	0.87	0.50	0.50	0.12
Myoblast, donor2	11322-117D8	118.91	23.21	4.41	3.64	1.73	0.77	0.58	0.38	0.38
Myoblast, donor3	11398-118D3	114.52	25.56	7.23	4.71	3.20	1.35	1.18	0.34	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	164.32	34.73	5.25	4.96	1.90	3.94	2.04	0.73	0.73
Natural Killer Cells, donor1	11230-116C6	105.48	23.06	2.15	3.38	1.85	6.77	1.54	1.23	2.15
Natural Killer Cells, donor2	11311-117C6	104.34	22.01	1.51	0.90	3.92	6.63	0.60	2.41	0.90
Natural Killer Cells, donor3	11387-118C1	120.00	27.42	1.84	1.84	1.10	7.18	0.92	0.74	0.55
Neural stem cells, donor1	11275-116H6	291.08	77.67	7.26	7.62	2.18	2.90	1.09	0.36	0.00
Neural stem cells, donor2	11352-117H2	165.61	32.74	1.93	3.85	3.85	1.93	3.85	0.00	0.00
Neurons, donor1	11494-119E9	119.48	34.14	3.41	4.55	3.41	3.41	1.14	0.00	1.14
Neurons, donor2	11574-120E8	109.86	29.50	2.20	4.40	1.54	1.54	0.66	0.22	0.22
Neurons, donor3	11655-122E8	65.77	22.20	0.00	2.47	0.00	0.82	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	168.90	26.91	4.64	0.93	1.86	0.93	0.93	1.86	0.00
Neutrophils, donor2	11314-117C9	208.72	40.58	5.80	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	276.10	63.53	11.00	3.05	1.83	3.05	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	137.85	20.90	5.11	3.68	1.90	0.24	0.71	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	95.08	13.35	2.28	1.30	0.65	0.00	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	88.84	15.44	4.01	2.21	2.01	0.40	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	67.86	12.53	1.24	1.24	1.24	0.41	0.41	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	91.04	15.92	1.59	2.32	0.58	0.43	0.58	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	83.77	14.30	1.36	2.04	1.02	0.45	0.23	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	158.56	31.17	2.63	2.63	1.56	0.49	0.29	0.39	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	107.12	28.89	7.22	2.41	3.01	2.41	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	84.65	17.44	1.70	3.40	0.85	0.00	0.43	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	52.58	6.86	2.29	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	61.45	9.93	0.00	1.24	2.48	0.00	0.62	0.00	1.24
Osteoblast, donor1	11277-116H8	84.04	13.88	3.32	2.35	1.95	0.78	0.59	0.20	0.00
Osteoblast, donor2	11354-117H4	165.04	42.14	9.13	4.21	4.21	4.92	2.11	1.40	0.70
Osteoblast, donor3	11426-118G4	128.85	22.75	11.37	5.51	4.62	0.89	1.78	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	146.40	24.26	5.22	4.89	2.86	1.35	0.76	0.08	0.00
Pericytes, donor1	11491-119E6	13.13	4.90	0.56	0.45	0.45	0.00	0.33	0.00	0.22
Pericytes, donor2	11571-120E5	26.71	5.89	0.00	0.45	0.23	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	49.44	10.78	1.42	1.63	1.22	1.02	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	126.81	25.20	8.48	5.76	3.39	1.02	1.13	0.68	0.11
Perineurial Cells, donor2	11579-120F4	109.31	18.68	9.75	3.31	2.30	0.92	0.55	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	119.53	37.93	1.59	2.23	1.59	14.02	0.96	1.27	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	71.50	18.85	1.47	1.71	1.71	2.45	0.24	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	93.83	20.45	3.11	2.33	1.55	5.82	0.52	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	30.37	6.94	0.48	1.20	0.48	0.24	0.72	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	29.94	7.76	1.11	1.11	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	40.25	8.64	2.94	2.75	0.79	0.39	0.79	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.11	8.23	0.00	2.53	1.58	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	84.60	14.63	0.94	1.69	0.94	0.19	0.56	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	145.28	26.11	8.61	4.31	2.61	0.26	1.04	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	89.83	12.61	3.60	4.05	1.13	0.68	0.23	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	110.93	19.29	2.02	4.48	1.49	0.11	0.53	0.32	0.00
Preadipocyte - omental, donor2	11329-117E6	94.28	20.08	2.18	2.18	1.75	0.87	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	114.03	22.35	4.58	3.72	2.15	0.72	0.57	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	54.13	4.92	1.97	2.95	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	69.41	9.83	3.38	4.30	0.61	0.00	0.61	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	226.84	39.13	14.52	9.21	3.72	2.48	0.71	1.24	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	97.57	16.01	8.68	4.77	2.55	0.68	0.34	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	210.61	36.89	7.17	6.99	4.28	2.24	0.93	0.56	0.00
Preadipocyte - visceral, donor2	11357-117H7	167.51	32.21	7.36	9.20	1.84	0.92	0.46	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	129.05	23.72	8.78	5.33	3.97	1.46	0.94	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	217.23	69.09	9.35	7.24	5.58	5.58	5.13	1.21	0.30
Prostate Epithelial Cells, donor2	11331-117E8	74.07	18.15	1.62	2.44	1.49	0.41	0.41	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	95.22	22.41	1.59	1.90	0.80	0.73	1.22	0.06	0.12
Prostate Stromal Cells, donor1	11254-116F3	166.41	30.87	7.29	6.26	3.99	1.71	2.05	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	183.96	31.74	10.22	7.53	3.77	1.26	1.26	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	84.25	12.51	3.65	2.61	1.67	0.31	0.10	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.55	10.95	1.46	1.09	0.73	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	106.74	25.02	3.05	3.95	1.59	0.49	0.62	0.14	0.14
Renal Epithelial Cells, donor1	11517-119H5	25.87	8.12	1.01	1.01	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	39.12	7.11	4.27	1.42	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	120.90	30.17	3.18	4.02	1.91	0.74	0.85	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	32.68	11.57	0.00	0.00	0.00	0.68	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	77.35	23.18	1.89	1.08	0.94	1.48	1.21	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	225.79	48.40	12.43	7.33	4.22	1.78	2.22	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	6.65	0.67	1.33	1.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	35.65	9.90	1.76	0.88	1.32	1.32	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	55.17	14.42	1.25	3.76	0.63	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	19.42	7.49	0.83	0.83	0.55	0.28	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	81.60	27.38	4.03	5.10	1.07	1.34	0.81	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	44.70	10.54	0.84	0.84	0.84	0.00	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	56.50	17.55	2.70	1.93	2.12	0.58	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	116.16	30.08	3.63	5.19	3.89	0.52	0.78	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	56.28	20.18	0.28	2.27	0.85	0.85	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	36.02	17.50	0.00	1.03	1.03	3.09	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	103.12	26.85	1.25	2.01	1.00	0.75	0.50	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	123.48	31.27	2.27	3.74	1.87	0.67	0.67	0.80	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	115.25	34.84	0.89	3.57	3.57	5.36	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	148.05	60.54	3.30	3.85	2.20	4.95	1.10	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	204.76	64.97	2.90	5.22	1.74	3.48	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	272.01	113.12	6.24	6.76	3.51	4.94	4.68	1.04	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	232.37	72.00	5.96	6.65	3.18	3.67	4.57	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	178.80	61.01	7.25	4.13	1.78	3.90	3.01	1.12	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	240.77	82.24	12.03	5.95	5.21	4.34	5.33	1.61	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	214.09	73.42	6.18	5.94	4.08	3.96	2.68	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	208.71	83.21	4.16	6.70	2.08	4.62	4.85	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	253.14	98.71	11.91	5.20	3.97	4.79	3.29	0.82	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	204.98	69.89	8.32	6.05	2.87	3.48	4.54	1.21	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	185.82	57.70	5.20	5.38	1.79	3.40	3.23	1.43	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	204.86	79.62	9.18	5.31	3.59	2.87	1.58	0.57	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	210.98	65.03	5.37	5.90	2.79	3.65	4.19	0.32	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	201.36	61.29	5.97	6.20	3.10	3.10	2.88	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	297.09	117.38	12.62	7.84	4.97	4.40	3.82	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	249.77	84.22	6.15	6.80	3.45	5.22	5.78	0.65	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	245.78	102.41	3.95	4.89	3.76	4.70	3.19	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	354.46	141.07	10.35	8.63	3.58	5.44	5.97	0.40	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	267.40	85.95	8.27	5.65	2.92	3.80	3.41	0.58	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	210.82	67.60	4.96	6.87	2.10	5.16	2.86	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	284.07	106.37	10.15	5.87	5.66	3.63	4.16	0.32	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	238.54	67.27	5.33	6.17	3.36	3.92	4.77	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	276.34	89.72	5.47	4.61	2.39	4.79	3.59	0.85	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	296.65	112.68	9.66	5.83	2.92	5.83	3.65	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	223.80	64.14	5.52	6.01	3.43	2.82	4.54	0.86	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	199.06	62.32	7.79	6.72	3.90	3.49	2.82	1.75	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	216.53	93.64	7.55	6.13	4.95	3.77	3.30	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	215.08	64.29	5.56	5.95	2.98	2.98	2.98	0.99	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	209.76	70.62	5.38	5.61	1.87	3.04	2.81	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	207.15	87.71	11.82	4.98	5.60	4.15	3.53	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	238.91	85.17	3.98	8.85	3.32	1.11	3.10	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	255.88	71.02	6.89	7.31	2.51	2.30	5.22	0.84	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	269.98	93.40	10.36	8.61	5.79	4.58	4.44	0.81	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	334.12	96.22	10.05	6.81	4.43	6.30	4.94	0.51	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	282.64	85.22	8.87	5.01	2.89	4.63	6.17	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	243.64	99.38	12.72	6.02	4.13	4.30	3.61	0.52	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	306.44	77.77	9.88	6.72	4.12	3.70	4.80	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	260.37	80.44	5.91	6.24	3.45	5.25	3.78	0.82	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	235.71	90.16	10.06	3.92	5.28	2.39	3.24	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	224.30	59.18	7.84	7.84	4.73	1.63	2.22	0.89	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	237.76	72.77	7.46	5.86	2.13	3.20	5.33	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	197.44	87.11	8.99	6.64	3.73	2.35	3.46	0.69	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	141.91	51.91	6.90	5.00	2.38	2.14	2.62	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	283.57	109.84	9.07	5.84	2.42	5.24	5.04	0.40	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	153.03	54.15	5.46	4.52	2.26	2.64	2.07	0.38	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	158.61	66.03	3.49	8.38	0.70	2.79	2.79	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	198.86	55.91	6.65	7.56	1.51	4.53	3.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	170.97	72.45	5.63	4.53	3.67	3.43	2.81	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	257.77	81.36	4.51	5.24	2.47	5.24	4.80	3.49	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	137.50	46.85	4.87	1.83	2.43	2.43	4.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	160.65	62.69	5.73	4.52	3.92	1.81	1.21	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	166.25	58.13	5.65	5.43	3.62	2.49	2.26	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	171.64	56.61	6.59	4.49	1.80	4.79	2.70	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	135.43	66.12	4.13	4.37	3.07	3.78	2.72	0.94	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	153.68	51.65	3.20	3.42	3.42	3.63	2.13	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	146.64	54.09	3.61	1.80	2.40	3.00	2.40	0.60	0.60
Schwann Cells, donor1	11498-119F4	56.99	14.48	2.07	2.07	1.88	0.19	0.56	0.00	0.19
Schwann Cells, donor2	11578-120F3	105.47	30.62	3.40	17.01	0.00	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	113.70	22.13	8.76	6.57	3.72	0.66	0.44	0.00	0.22
Sebocyte, donor1	11220-116B5	155.02	43.27	2.19	7.12	2.19	1.64	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	126.84	28.49	0.92	3.68	1.38	1.84	1.84	0.46	0.00
Sebocyte, donor3	11378-118B1	61.22	13.81	1.24	2.27	1.03	0.21	0.62	0.21	0.21
Sertoli Cells, donor1	11255-116F4	147.44	18.22	6.63	9.94	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	149.69	28.24	2.82	5.65	11.30	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	128.98	22.79	5.37	4.05	2.02	1.06	0.79	0.97	0.18
Skeletal Muscle Cells, donor2	11358-117H8	40.48	7.23	1.45	1.45	0.72	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	94.47	25.92	4.18	5.02	2.51	0.84	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	148.77	42.73	10.68	5.18	6.28	1.57	1.10	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	144.78	39.24	7.43	5.95	4.91	1.64	1.19	0.45	0.59
Skeletal Muscle Cells, donor6	11459-119B1	170.22	48.63	11.54	6.31	3.85	1.85	1.54	0.62	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	190.14	38.05	6.05	4.66	3.15	0.76	0.25	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	152.53	34.10	6.28	5.85	2.85	1.28	0.71	0.43	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	203.08	49.90	13.79	8.33	4.27	1.79	1.39	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	115.68	26.29	3.45	3.96	2.11	0.67	1.18	0.42	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	91.92	28.23	9.41	2.90	0.72	0.72	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	50.09	10.87	2.48	1.79	1.24	0.41	0.14	0.14	0.55
Skin - palm, donor1	10286-104F7	136.99	21.49	0.00	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	77.99	20.61	1.59	3.89	0.58	1.01	0.58	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	137.41	57.25	0.00	8.18	4.09	7.36	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	88.41	19.21	0.91	3.51	2.47	0.78	1.17	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	101.75	24.19	1.81	3.75	0.97	0.14	0.83	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	139.95	29.54	4.64	4.36	1.83	1.27	0.70	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	197.91	49.27	10.57	5.50	2.33	3.59	2.33	1.90	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	157.62	38.90	2.10	3.07	0.97	0.67	1.20	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	116.03	25.30	5.25	4.63	1.85	0.31	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	260.79	51.80	10.23	5.34	3.78	1.78	1.33	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	98.17	20.57	3.53	5.88	1.18	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	98.56	10.83	1.77	3.09	0.88	0.88	0.66	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	63.79	10.63	2.36	0.79	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	98.12	16.22	6.18	3.09	2.32	1.55	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	72.05	15.01	2.00	2.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	102.07	19.56	2.66	3.06	1.60	0.13	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	94.87	12.63	6.65	4.21	2.44	1.77	0.22	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	142.24	27.14	7.30	3.46	4.61	0.90	1.41	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	106.47	22.47	3.91	3.26	1.30	0.00	0.65	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	127.58	30.12	10.63	4.73	3.54	0.00	1.48	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	110.33	17.65	4.56	3.70	1.85	0.71	0.43	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	21.47	5.53	0.65	0.33	0.33	0.16	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	143.39	28.92	3.65	6.09	0.91	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	87.89	16.16	3.03	1.26	2.27	0.51	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	18.36	0.00	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	68.66	12.40	2.86	4.29	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	102.94	17.84	3.10	2.80	2.51	0.74	0.59	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	132.37	26.47	3.44	3.87	2.58	0.86	0.65	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	127.42	26.76	7.66	5.25	3.88	0.73	1.26	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	70.38	11.76	2.17	3.56	2.01	0.31	0.77	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	68.98	14.01	5.39	2.16	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	81.89	13.75	2.39	4.18	1.49	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.77	11.61	3.41	1.37	0.68	0.34	0.68	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	143.63	26.23	2.28	3.53	1.81	0.39	0.31	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	160.02	28.38	2.82	2.31	4.33	0.81	1.11	0.30	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	111.27	17.52	7.05	5.01	2.28	0.46	0.23	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	53.74	12.08	1.81	1.81	1.21	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	229.69	70.47	21.72	10.60	6.36	3.97	3.97	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	126.50	28.23	5.06	3.86	4.13	1.86	1.07	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	115.58	19.78	6.26	4.13	3.01	0.75	0.25	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	66.71	8.12	3.30	1.01	2.28	0.25	0.51	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	112.48	18.39	3.77	3.62	2.11	0.45	0.30	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	75.77	8.25	1.50	2.25	3.00	1.50	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	400.59	32.31	7.75	10.34	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	88.83	13.95	1.40	2.79	2.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	70.18	13.63	2.52	1.51	2.02	1.01	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	76.47	11.60	1.25	0.94	1.88	0.94	1.25	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	4.72	0.29	1.47	0.00	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	244.92	60.31	17.49	7.83	5.33	3.92	2.58	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	133.61	14.01	2.80	3.27	1.40	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	78.29	14.82	2.88	1.87	1.15	0.14	0.72	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	84.14	19.89	3.82	2.55	2.04	0.76	1.53	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.02	13.73	4.70	3.76	0.94	1.32	0.75	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	138.77	38.43	10.20	5.73	2.93	1.54	1.26	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	106.83	17.68	6.37	4.11	2.35	0.25	0.34	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.43	4.76	0.48	0.00	0.00	0.00	0.95	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	78.29	16.88	3.43	1.71	0.73	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	105.17	19.22	5.52	3.09	3.31	0.88	0.66	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	88.07	20.77	4.97	2.05	0.59	0.59	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	86.49	12.83	1.17	4.08	0.58	0.00	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	84.89	17.45	1.06	3.70	3.17	1.06	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	72.16	11.53	0.74	0.74	0.74	0.00	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	111.39	22.28	0.00	5.39	0.36	0.36	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	88.29	23.00	1.14	3.97	1.42	0.57	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	128.01	37.02	0.79	6.30	0.79	0.39	1.97	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	82.53	14.98	0.25	5.33	1.78	0.51	1.02	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	103.02	15.17	3.19	3.19	2.00	0.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.13	14.21	0.42	0.84	1.25	0.42	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	51.79	12.38	0.46	0.92	1.38	0.00	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	104.70	15.65	3.20	2.36	1.01	0.00	0.34	0.17	0.00
Synoviocyte, donor2	11368-117I9	63.86	9.05	3.02	2.01	1.34	0.34	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	65.91	10.95	1.79	1.79	1.79	0.00	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	72.54	25.73	2.50	2.14	2.86	1.43	0.36	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	67.39	25.77	0.00	3.96	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	67.38	15.28	2.08	2.08	1.39	0.00	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	81.22	17.13	1.79	2.15	1.00	0.29	0.36	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	46.77	13.92	2.32	1.16	0.77	0.00	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	54.98	9.16	1.72	1.15	0.00	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	120.56	34.20	1.48	2.83	1.85	0.98	1.48	0.37	0.12
Urethra, donor2	10319-105A4	187.04	46.76	0.00	0.00	3.60	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	6.64	0.00	1.33	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	25.64	6.41	0.80	0.80	0.40	0.00	0.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	23.15	4.81	0.23	1.15	0.46	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	108.77	24.07	2.01	2.23	2.45	0.67	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	152.15	28.47	5.34	2.67	2.67	4.45	1.78	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	184.42	37.17	4.29	4.29	0.00	10.01	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	128.69	27.38	0.00	4.11	0.00	2.05	1.37	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	137.74	23.41	2.41	2.41	1.38	4.48	0.69	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	127.25	33.12	0.58	1.16	1.74	4.07	0.00	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	161.39	34.36	1.04	2.08	3.12	5.21	0.00	5.21	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	122.98	38.55	3.67	4.59	0.00	10.10	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	114.11	28.30	2.74	0.91	2.74	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	146.68	42.93	13.82	6.04	2.47	1.85	2.84	0.25	0.37
Wilms' tumor cell line:HFWT	10597-108E3	277.21	58.96	12.32	9.68	5.28	6.16	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	111.17	26.81	4.19	4.75	1.96	1.68	1.68	0.28	0.00
achilles tendon, donor2	10292-104G4	62.00	12.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	181.78	66.29	4.59	3.57	1.78	9.43	4.08	1.53	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	173.67	60.13	8.36	5.57	3.95	4.64	1.63	0.23	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	201.09	62.56	8.90	6.77	3.21	29.80	4.27	1.07	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	177.42	61.77	7.89	3.27	4.35	20.14	3.81	1.09	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	175.12	40.19	8.43	5.62	3.09	1.12	0.84	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	153.54	45.68	9.73	5.29	4.44	2.11	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	85.75	18.24	1.09	4.36	1.09	0.82	0.27	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	191.24	46.71	8.81	3.97	3.08	7.05	2.20	2.64	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	99.23	33.08	2.86	6.13	2.86	1.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	98.63	21.74	12.04	2.72	1.55	1.16	0.78	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	128.25	37.35	5.34	4.78	4.42	2.21	0.37	0.92	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	132.62	35.10	19.50	7.80	0.00	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	164.76	45.55	12.78	10.46	4.18	2.09	2.09	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	203.24	55.66	5.18	5.44	2.59	6.99	1.81	1.29	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	210.42	48.80	9.35	7.60	5.84	0.58	0.88	0.88	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	162.67	42.29	1.86	4.18	3.72	1.39	1.39	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	107.75	25.91	3.29	0.82	1.23	1.23	0.41	2.06	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	154.40	40.82	6.75	6.45	1.84	0.92	3.07	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	177.94	49.50	14.93	5.97	5.55	0.85	1.71	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	148.92	38.21	12.44	6.37	3.94	1.82	1.21	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	184.86	51.51	14.68	4.57	1.93	2.41	1.68	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	248.35	70.83	4.01	5.35	2.67	5.79	3.79	0.45	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	421.27	117.07	4.00	10.67	2.33	7.00	5.34	0.67	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	524.01	176.53	7.43	18.58	3.72	3.72	0.00	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	197.37	45.58	13.18	7.16	6.03	4.14	1.51	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	268.22	94.64	8.72	10.03	3.49	3.05	2.62	0.87	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	397.39	80.60	3.75	13.12	0.00	0.00	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	111.63	21.67	1.18	1.88	0.71	0.24	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	110.44	28.70	1.55	1.71	2.17	0.62	0.31	0.16	0.16
adipose, donor1	10184-103D4	253.33	70.37	11.14	9.38	3.52	0.00	1.76	0.00	0.00
adipose, donor2	10185-103D5	91.24	30.01	2.84	3.24	1.62	1.22	0.81	0.00	0.00
adipose, donor3	10186-103D6	128.52	41.12	3.81	6.53	2.45	2.72	2.45	0.54	0.82
adipose, donor4	10187-103D7	175.08	66.74	4.33	3.47	2.60	6.93	4.33	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	220.16	107.00	6.94	6.94	0.95	6.47	6.00	0.47	0.95
adrenal gland, adult, pool1	10081-102A9	69.12	10.91	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	118.86	36.69	2.40	1.47	1.60	1.33	0.67	0.40	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	248.68	61.10	3.93	8.58	2.86	1.07	2.14	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	62.14	10.67	2.09	2.55	0.93	0.00	0.70	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	72.69	13.19	4.40	2.70	1.35	0.34	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	91.92	20.03	0.88	2.06	1.47	0.59	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	94.86	26.09	2.37	2.37	1.19	0.00	1.19	1.19	1.19
amygdala, adult, donor10252	10151-102I7	137.88	45.22	2.43	4.87	1.42	1.22	0.00	0.81	1.82
amygdala, newborn, donor10223	10360-105E9	104.58	37.44	0.32	2.58	0.32	1.29	0.32	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	134.08	25.34	4.07	3.82	1.78	0.25	0.76	0.64	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	119.58	46.33	3.53	3.53	1.99	8.38	6.18	1.10	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	149.65	32.74	10.69	7.68	5.34	1.67	1.00	1.67	0.33
aorta, adult, pool1	10052-101G7	68.65	19.81	0.98	1.37	1.18	0.39	0.59	0.20	0.20
appendix, adult	10189-103D9	181.64	52.78	3.49	5.05	6.60	7.76	1.94	1.16	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	238.00	55.72	10.66	6.19	2.75	1.72	2.75	0.34	1.03
artery, adult	10190-103E1	114.13	27.17	1.36	1.36	2.72	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	179.06	49.11	8.26	5.50	6.37	1.16	1.59	0.58	0.00
b cell line:RPMI1788	10427-106D4	120.60	54.28	3.12	3.72	1.04	2.53	2.83	1.04	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	111.81	16.92	8.32	4.16	2.50	0.28	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	300.57	104.49	8.93	7.84	2.38	6.75	7.84	0.40	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	132.73	36.32	2.34	1.34	0.50	2.01	2.68	1.51	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	123.59	19.57	3.36	1.68	1.68	0.00	0.00	1.12	0.56
bladder, adult, pool1	10011-101C2	168.72	37.81	2.28	2.72	2.82	0.87	0.76	0.00	0.11
blood, adult, pool1	10053-101G8	50.94	6.64	6.64	0.00	2.21	0.00	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	139.58	29.12	5.14	5.99	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	138.34	31.72	0.00	4.72	4.05	2.70	0.67	2.02	0.00
brain, adult, donor1	10084-102B3	59.45	17.43	4.10	2.05	3.08	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	133.52	32.29	4.12	4.45	1.67	0.11	0.11	0.11	0.22
brain, fetal, pool1	10085-102B4	45.41	29.39	0.00	2.67	0.00	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	222.67	49.55	5.62	5.29	1.98	0.99	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	298.95	81.38	3.74	3.62	2.62	1.00	1.62	0.75	0.37
breast, adult, donor1	10080-102A8	78.29	33.46	0.63	1.26	0.63	1.26	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	64.15	28.20	2.29	3.56	2.67	3.05	1.02	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	188.32	65.25	2.78	10.51	2.16	1.86	3.40	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	128.46	41.44	1.84	2.99	1.61	1.15	1.38	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	123.46	33.89	1.21	2.66	1.69	1.94	1.21	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	244.02	87.45	7.99	8.93	5.64	2.35	3.29	1.41	0.47
carcinoid cell line:NCI-H727	10735-110B6	372.22	75.58	15.31	10.28	4.70	3.61	2.41	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	203.76	45.95	5.07	3.49	6.02	4.12	1.27	1.58	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	252.07	81.45	12.24	9.05	6.12	4.53	2.13	0.80	0.27
caudate nucleus - adult, donor10196	10177-103C6	99.01	40.30	1.15	4.61	2.30	1.15	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	106.92	32.96	3.68	3.51	1.34	0.84	1.51	0.33	1.51
caudate nucleus, adult, donor10258	10379-105H1	128.38	38.21	1.53	3.06	1.53	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	142.83	47.24	0.37	2.93	0.73	4.76	2.56	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	128.18	72.83	0.00	5.83	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	182.12	74.52	2.35	3.20	1.49	0.21	1.92	1.49	0.21
cerebellum, adult, pool1	10083-102B2	63.47	27.94	0.69	4.14	0.69	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	189.31	65.59	0.00	2.49	0.00	0.00	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	134.39	27.48	3.28	6.05	1.76	0.50	1.51	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	57.74	18.27	0.00	5.12	0.00	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	158.16	49.32	3.88	3.59	1.29	3.16	1.58	1.01	0.00
cervical cancer cell line:ME-180	10553-107I4	112.19	29.50	2.65	2.15	1.16	2.49	2.82	0.50	0.17
cervix, adult, pool1	10013-101C4	163.26	40.74	1.78	3.46	2.73	0.21	0.31	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	121.92	33.30	3.48	2.09	1.67	0.42	2.23	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	224.68	40.49	1.31	3.92	2.61	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	239.60	93.83	8.45	7.95	4.35	2.24	2.73	0.25	0.37
choriocarcinoma cell line:SCH	10785-110H2	123.83	35.49	8.26	5.67	3.20	3.08	2.59	0.49	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	175.51	84.91	8.30	5.93	2.37	3.56	4.27	0.71	0.47
chorionic membrane cells, donor1	12238-129G6	39.60	9.40	1.14	1.71	0.57	0.00	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	114.74	20.68	8.95	4.18	2.49	0.30	0.99	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	66.49	17.58	1.10	1.65	0.55	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	117.14	31.30	2.02	4.04	2.02	16.16	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	126.21	23.44	7.30	4.61	2.88	2.50	0.58	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	103.90	21.75	9.71	3.17	1.69	1.27	0.63	0.42	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	348.22	133.54	8.99	8.73	2.82	7.19	2.05	0.77	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	410.71	136.18	9.92	8.95	1.69	7.50	3.63	0.48	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	377.90	132.14	12.22	7.33	2.44	7.13	4.68	0.61	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	270.31	101.29	6.18	7.36	3.83	6.77	4.71	2.06	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	336.73	84.44	16.94	8.86	7.82	3.13	2.61	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	146.06	34.52	11.66	8.23	4.34	0.23	0.91	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	193.63	57.60	7.98	4.68	2.95	2.08	2.95	0.52	0.52
colon carcinoma cell line:CACO-2	10513-107D9	294.33	128.50	12.08	10.07	3.66	8.97	7.32	0.73	1.28
colon carcinoma cell line:COLO-320	10420-106C6	361.46	124.67	4.18	13.68	5.70	4.56	3.80	1.14	0.00
colon, adult, donor1	10082-102B1	78.54	20.23	1.19	1.19	3.57	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	153.34	34.08	0.82	5.17	3.76	0.24	0.24	0.12	0.12
colon, fetal, donor1	10070-101I7	74.16	21.63	0.00	1.24	0.62	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	421.68	82.50	9.17	13.75	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	259.21	99.43	3.82	6.37	5.10	8.92	2.55	2.97	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	270.62	104.14	7.09	7.85	4.08	4.08	2.41	3.17	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	258.76	92.08	6.20	9.02	2.68	5.22	2.54	2.54	0.42
corpus callosum, adult, pool1	10042-101F6	150.14	32.51	2.43	4.31	2.21	0.44	0.66	0.77	0.11
cruciate ligament, donor2	10295-104G7	80.24	14.59	2.43	0.81	1.62	0.81	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	89.08	25.68	1.61	0.80	0.00	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	97.92	19.20	3.36	4.08	2.88	2.16	0.24	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	184.61	34.21	7.12	7.81	2.07	1.84	0.46	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	223.62	106.94	3.08	6.67	2.05	7.95	5.90	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	168.02	32.98	10.59	4.33	2.89	1.69	1.20	0.48	0.24
ductus deferens, adult	10196-103E7	157.97	28.90	1.99	3.49	3.49	0.50	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	10.08	1.44	1.44	0.00	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	116.97	25.01	1.47	5.89	2.21	0.74	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	121.65	19.74	5.86	2.89	1.49	0.50	0.58	0.91	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	252.27	70.84	9.99	6.44	9.10	6.44	4.89	7.99	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	366.11	76.52	14.33	11.61	7.31	2.72	3.15	2.87	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	309.54	134.42	4.93	5.55	2.47	5.55	8.63	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	197.67	61.75	3.33	5.45	2.72	1.82	2.12	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	335.61	110.22	5.87	7.72	0.93	4.01	5.25	0.00	0.93
embryonic pancreas cell line:2C6	10603-108E9	319.17	114.27	11.82	6.57	3.94	9.19	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	195.42	75.42	12.07	5.70	5.70	4.36	5.03	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	122.33	33.71	4.53	2.54	1.81	1.63	1.27	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	112.25	27.18	3.06	2.25	1.29	0.96	0.64	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	222.43	53.02	5.34	4.45	2.33	2.45	1.67	0.33	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	335.57	91.51	12.21	8.25	4.62	5.06	6.60	0.22	0.33
epididymis, adult	10197-103E8	135.42	29.51	1.67	4.19	1.67	0.21	0.42	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	112.30	22.00	8.16	3.90	3.55	1.24	0.53	1.06	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	117.19	28.71	9.83	5.51	1.97	0.79	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	187.93	79.29	16.91	6.81	2.10	5.90	5.37	1.70	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	270.46	112.10	20.18	6.20	4.04	7.38	5.41	1.77	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	216.89	81.22	15.68	6.39	3.58	6.27	6.72	1.46	1.57
esophagus, adult, pool1	10015-101C6	138.14	30.15	2.02	3.29	1.91	0.21	0.74	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	303.95	45.59	13.78	8.64	6.64	0.88	0.50	0.50	1.63
eye - muscle inferior rectus, donor1	10272-104E2	137.63	41.05	2.41	2.41	0.00	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	77.86	31.56	0.00	2.10	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	83.34	23.81	0.00	4.46	1.49	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	74.52	33.25	2.29	2.29	1.15	1.15	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	8.74	1.46	2.91	1.46	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	80.85	19.58	2.80	3.56	1.53	0.25	0.25	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	64.11	17.18	4.23	1.54	1.41	1.03	1.03	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	262.82	105.65	7.60	6.41	3.56	6.41	7.83	0.71	0.47
frontal lobe, adult, pool1	10040-101F4	125.07	27.96	3.28	4.22	3.00	0.38	0.66	0.09	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	172.94	61.25	7.51	3.90	3.90	3.90	5.70	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	235.54	50.66	5.85	5.94	3.11	0.91	1.01	0.00	0.00
gall bladder, adult	10198-103E9	130.86	22.94	1.45	2.90	2.41	0.24	0.72	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	84.29	31.67	2.15	2.15	1.61	6.98	2.15	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	76.19	18.67	1.87	0.75	1.49	1.49	0.00	1.87	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	157.57	38.23	3.17	3.38	1.06	1.48	1.48	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	198.25	50.67	8.70	6.00	3.48	1.35	1.55	1.93	0.00
gastric cancer cell line:AZ521	10549-107H9	270.20	105.92	11.31	9.51	2.46	10.17	7.38	2.30	1.64
gastric cancer cell line:GSS	10560-108A2	135.45	63.15	3.66	4.58	2.75	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	199.90	62.60	9.14	4.34	3.43	2.74	2.97	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	88.12	51.29	0.57	1.03	0.23	8.03	3.21	0.34	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	181.53	46.47	7.14	3.64	3.36	1.12	0.28	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	329.23	110.99	5.24	8.23	1.50	3.24	5.49	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	204.88	50.45	2.43	3.38	2.64	2.11	2.01	0.95	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	163.75	40.59	3.51	3.37	1.83	2.25	1.97	0.28	0.98
glioblastoma cell line:T98G	10485-107A8	155.74	25.83	7.62	4.30	3.53	1.77	0.99	0.22	0.55
glioma cell line:GI-1	10413-106B8	232.54	72.63	7.03	5.86	4.10	2.64	1.76	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	86.74	29.16	0.73	2.92	0.00	0.00	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	156.22	46.13	6.10	2.93	2.93	0.49	0.73	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	123.23	23.28	1.37	9.58	2.74	1.37	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	99.12	29.31	0.00	2.66	0.53	3.73	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	354.84	75.86	36.71	7.34	0.00	9.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	202.24	41.60	4.48	4.80	1.92	1.92	2.56	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	131.77	85.40	5.05	5.05	4.13	9.18	7.35	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	112.94	84.14	2.29	4.12	3.20	9.15	5.03	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	84.38	65.05	1.93	4.51	1.29	10.31	6.44	0.00	1.29
hIPS, biol_rep1	14380-156B6	45.99	60.37	1.44	5.75	0.00	12.94	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	80.93	67.90	1.37	4.80	2.06	13.03	7.54	0.69	3.43
hIPS, biol_rep3	14382-156B8	90.48	51.86	1.10	2.21	0.00	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	114.36	58.62	4.60	4.02	0.86	1.72	1.44	0.57	1.72
heart - mitral valve, adult	10205-103F7	141.71	30.79	1.20	2.09	1.20	0.30	0.60	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	166.56	38.18	1.31	5.23	1.57	0.52	0.26	1.05	0.00
heart - tricuspid valve, adult	10207-103F9	169.03	69.11	6.66	2.50	4.16	5.00	3.33	0.83	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	81.21	24.08	4.08	4.29	1.63	2.45	1.02	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	63.87	12.35	0.00	1.70	0.00	0.00	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	146.50	38.87	2.30	3.22	1.84	0.00	1.15	0.00	0.00
heart, fetal, pool1	10046-101G1	170.55	49.70	3.59	4.00	4.62	0.41	1.44	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	106.75	14.50	2.47	3.39	2.16	0.93	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	299.67	132.00	2.38	2.38	1.19	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	243.75	74.47	30.17	8.84	7.07	2.43	3.65	0.99	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	255.61	72.46	36.17	8.25	7.28	2.67	3.03	0.85	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	278.91	79.53	33.95	10.91	10.31	2.93	4.24	1.72	0.30
hepatoma cell line:Li-7	10484-107A7	145.92	30.36	6.45	2.78	1.56	2.00	1.56	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	150.55	56.58	10.75	4.32	2.41	5.23	3.02	0.00	0.40
hippocampus - adult, donor10196	10169-103B7	127.75	27.44	0.95	2.84	0.00	1.89	0.00	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	136.54	47.76	2.86	3.27	2.86	0.61	0.82	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	58.26	24.90	0.00	4.98	1.49	0.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	108.21	31.72	0.35	2.82	0.70	1.06	1.06	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	185.54	86.06	3.05	6.71	3.05	15.26	6.71	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	132.93	74.81	2.55	3.73	1.57	12.57	5.50	0.79	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	181.54	103.08	3.05	6.35	2.03	16.00	5.08	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	156.19	49.62	4.51	9.59	3.95	2.82	1.69	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	172.23	71.01	8.00	5.94	1.55	2.58	2.84	0.26	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	192.46	55.04	3.42	8.35	4.93	4.56	1.90	1.14	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	157.36	42.04	2.34	6.13	3.50	3.50	0.29	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	130.98	39.42	3.45	5.39	2.80	2.80	2.15	1.08	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	148.48	46.71	1.67	2.50	3.34	2.09	2.92	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	146.81	38.12	5.21	7.58	2.84	1.18	0.95	0.71	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	164.74	43.23	8.84	7.55	3.70	1.93	2.09	0.64	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	142.07	37.03	6.73	3.37	1.35	1.35	2.02	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	148.97	81.37	5.01	5.48	1.41	13.93	6.73	1.10	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	125.28	72.71	4.42	2.95	3.44	15.23	4.42	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	198.11	125.68	0.87	5.24	0.87	7.85	6.98	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	178.12	54.98	3.63	4.39	1.91	2.67	1.15	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	149.57	47.10	3.05	6.98	2.62	2.18	0.87	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	175.92	53.47	2.50	6.50	5.00	2.50	2.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	96.46	25.06	2.07	4.14	2.45	0.75	0.38	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.94	30.01	4.55	4.09	2.27	0.45	1.36	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	109.01	28.50	1.25	6.58	2.82	0.94	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	104.35	24.50	4.41	4.74	1.31	0.49	0.98	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	96.96	21.77	2.32	3.77	2.03	1.45	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	132.12	29.29	2.39	6.58	2.99	0.30	0.60	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	130.25	66.69	6.28	4.06	1.29	15.70	5.36	1.11	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	114.68	63.62	4.56	4.28	2.28	13.69	5.99	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	184.56	97.99	4.90	4.08	1.22	16.74	7.76	0.82	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	133.79	54.22	4.93	6.69	4.93	7.04	3.17	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	120.68	46.56	4.12	4.12	3.17	2.85	1.27	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	139.51	48.42	3.63	6.96	3.63	3.93	0.91	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	68.78	23.27	2.59	4.65	1.55	2.07	1.55	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	74.39	19.92	1.99	3.98	1.99	0.66	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	113.64	25.14	3.08	7.44	3.85	1.80	0.51	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	113.25	32.21	6.90	5.62	2.81	0.51	1.02	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	108.28	29.53	2.27	6.82	4.54	0.00	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	136.78	30.58	2.69	5.38	2.02	2.02	1.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	128.24	80.90	6.76	4.11	2.90	14.01	10.38	0.72	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	201.44	97.15	2.67	5.35	4.01	13.82	9.36	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	163.42	80.98	0.98	4.88	3.41	13.17	4.88	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	149.45	54.40	4.58	6.42	2.75	1.83	2.75	0.92	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	351.35	152.90	6.51	22.77	3.25	6.51	3.25	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	164.15	52.62	2.98	5.30	3.31	2.65	2.98	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	113.84	31.20	4.38	7.66	2.19	1.64	0.55	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	122.32	35.10	1.45	6.88	2.17	2.17	1.45	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	119.93	29.89	3.91	4.27	4.27	1.42	1.42	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	130.08	47.74	2.39	2.39	2.39	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	181.61	50.24	6.77	7.18	5.01	2.17	2.30	0.14	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	123.65	35.83	1.08	5.93	4.58	0.27	0.81	0.54	0.27
immature langerhans cells, donor1	11904-125F5	68.53	14.77	4.12	1.94	0.24	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	55.45	14.26	2.38	3.17	0.00	0.00	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	141.48	35.20	2.27	4.07	2.93	0.57	0.28	0.38	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	55.28	14.31	1.30	0.98	1.95	2.60	0.98	0.33	0.65
kidney, adult, pool1	10017-101C8	123.26	29.14	2.50	2.40	1.80	0.20	0.60	0.30	0.10
kidney, fetal, pool1	10045-101F9	87.50	24.83	2.41	3.11	1.84	0.50	0.78	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	323.10	82.80	11.36	10.37	4.69	2.41	4.40	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	142.94	20.87	3.18	2.49	1.80	0.55	0.69	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	262.04	100.01	5.14	6.97	3.12	12.29	7.71	0.55	0.37
left atrium, adult, donor1	10079-102A7	65.93	23.97	1.09	0.00	0.54	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	63.71	17.70	1.01	1.52	2.02	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	246.80	50.07	7.93	6.57	3.28	2.19	1.92	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	84.06	14.01	1.80	1.08	1.80	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	70.11	11.96	1.63	3.26	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	94.94	20.40	3.16	3.89	1.21	0.49	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	430.77	54.37	16.73	17.77	2.09	2.09	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	259.61	55.02	18.18	7.91	6.61	2.95	1.30	1.30	0.71
liposarcoma cell line:KMLS-1	10782-110G8	83.88	17.34	2.66	2.81	1.56	0.94	0.47	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	175.57	31.07	13.77	5.85	3.29	2.07	1.83	0.24	0.00
liver, adult, pool1	10018-101C9	139.37	30.31	0.49	1.46	0.32	0.49	0.81	0.16	0.16
liver, fetal, pool1	10086-102B5	36.69	13.17	0.00	0.94	0.94	1.88	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	148.60	52.93	1.02	3.79	1.31	0.44	1.17	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	127.71	38.94	4.24	2.40	2.58	0.18	0.37	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	72.23	13.54	1.13	3.10	1.41	0.56	0.85	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	202.74	63.51	0.84	2.52	0.84	2.52	2.94	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	128.02	36.26	3.60	1.66	0.83	1.80	1.52	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	184.76	70.32	1.38	0.69	0.69	2.07	0.69	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	211.83	35.59	14.10	8.30	3.56	1.05	1.05	0.53	0.13
lung, adult, pool1	10019-101D1	129.94	37.68	1.65	2.84	1.30	0.59	0.71	0.35	0.12
lung, fetal, donor1	10068-101I5	173.53	55.94	0.86	6.28	3.71	1.71	0.29	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	98.52	28.41	2.29	3.21	1.83	2.29	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	86.63	17.99	1.89	2.37	2.37	0.47	1.42	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	109.15	33.53	0.88	1.32	0.44	3.73	1.75	0.00	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	128.14	45.13	10.26	4.83	0.60	4.38	1.66	0.30	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	202.18	86.65	4.25	5.10	1.70	5.95	6.80	3.40	0.00
mature adipocyte, donor1	12231-129F8	150.51	35.52	2.66	4.44	1.78	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	120.57	28.64	1.25	2.49	1.25	0.21	0.62	0.00	0.21
mature adipocyte, donor3	12233-129G1	140.10	33.19	1.90	2.37	1.42	0.00	0.71	0.00	0.00
mature adipocyte, donor4	12234-129G2	160.56	41.06	1.05	6.05	1.84	0.79	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	342.62	153.92	5.48	4.53	1.19	5.00	7.86	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	107.16	32.71	2.26	4.51	1.13	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	132.41	41.38	4.23	3.68	1.47	0.55	0.92	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	101.98	26.37	0.32	5.40	0.95	0.32	0.32	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	147.14	42.65	0.43	3.41	1.71	0.43	1.28	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	148.33	42.36	2.53	2.36	0.68	0.68	0.34	0.51	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	142.61	44.57	3.18	4.03	1.70	0.42	0.64	0.64	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	19.26	0.00	7.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	588.50	43.06	0.00	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	100.14	30.51	0.72	2.15	1.08	0.36	0.72	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	83.72	33.10	0.65	0.65	0.65	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	142.11	42.42	3.41	2.01	1.55	0.77	0.93	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	131.09	35.92	2.78	3.92	1.71	0.16	0.41	0.33	0.08
medulla oblongata, newborn, donor10223	10361-105F1	142.69	43.40	1.39	2.78	3.47	0.69	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	534.93	138.60	19.71	14.61	9.08	3.99	1.55	1.11	1.11
medulloblastoma cell line:ONS-76	10759-110E3	196.00	38.88	9.42	6.48	2.93	3.06	2.32	0.12	0.49
melanoma cell line:COLO 679	10514-107E1	102.63	25.01	8.77	3.74	1.29	1.15	0.57	0.14	0.00
melanoma cell line:G-361	10465-106H6	149.03	32.85	6.24	4.34	4.07	0.27	0.54	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	84.48	10.85	2.17	2.71	1.09	0.00	0.18	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	551.60	131.29	12.34	18.50	13.22	14.98	2.64	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	341.14	101.10	20.22	12.96	7.26	10.11	3.37	1.56	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	137.94	23.48	13.20	3.84	2.61	1.38	0.46	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	120.88	20.72	10.18	4.18	2.00	0.55	0.36	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	131.27	29.82	3.31	5.80	4.14	0.41	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	99.74	18.54	3.93	1.83	0.98	0.14	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	111.69	15.98	3.66	3.47	2.31	0.39	0.39	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	90.23	9.72	0.00	0.69	1.39	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	108.30	18.54	5.66	1.72	1.37	0.34	0.34	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	134.57	22.08	7.25	4.37	2.07	1.04	0.92	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	98.28	16.58	5.70	2.12	2.52	0.27	0.66	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	136.39	22.82	7.97	5.54	3.65	0.81	0.68	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	160.76	36.85	7.97	4.55	3.13	0.71	1.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	105.72	19.43	2.31	3.29	0.99	0.33	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	140.45	26.98	8.58	4.29	2.35	1.11	0.97	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	134.40	32.46	5.93	3.49	3.14	2.09	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	109.23	13.88	5.92	2.65	2.45	0.41	0.41	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	78.36	16.53	2.52	3.59	1.44	0.36	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	100.76	17.28	3.31	2.48	1.86	0.31	0.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	89.37	17.56	1.60	2.74	1.37	0.46	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	201.39	33.98	13.01	7.97	7.13	2.10	1.68	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	99.82	15.24	6.87	3.59	2.54	0.00	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	100.57	19.52	4.20	2.98	1.40	0.18	0.53	0.00	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	103.82	22.09	2.58	1.47	1.47	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	99.87	16.88	4.01	2.86	2.29	0.86	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	167.14	40.00	5.89	10.53	3.37	1.26	2.95	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	72.15	9.13	4.11	2.74	3.65	0.46	0.46	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	87.73	16.11	4.86	3.07	3.33	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	101.56	21.46	4.97	4.19	1.31	0.52	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	99.82	12.63	3.70	4.01	1.85	0.31	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	103.32	16.00	3.53	4.47	1.65	0.24	0.47	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	97.81	17.26	4.74	5.08	3.05	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	104.53	11.40	5.89	1.96	3.54	1.18	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	104.73	12.51	2.32	3.71	2.32	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	91.14	17.31	4.33	4.33	1.44	0.00	0.58	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	98.16	10.71	4.46	4.02	2.01	0.22	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	100.71	13.94	5.05	2.16	2.88	0.72	0.00	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	197.27	24.93	8.07	6.60	2.20	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	91.30	16.78	2.35	2.01	2.35	1.34	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	95.39	15.56	4.09	2.87	1.23	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	93.64	15.46	1.29	5.58	3.44	1.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	76.56	2.73	0.00	0.00	5.47	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	80.55	13.64	0.97	0.97	2.27	0.65	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	10.18	1.45	2.91	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	61.84	10.13	1.60	0.53	0.00	0.53	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	13.08	0.82	6.54	2.45	2.45	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	64.92	13.61	2.33	1.55	1.17	0.39	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	62.96	8.39	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	59.61	12.92	0.99	0.99	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	19.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	77.09	15.42	1.78	1.19	2.37	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	70.67	9.75	3.66	1.22	2.44	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	72.84	13.30	1.90	0.63	2.53	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	69.67	10.00	1.72	0.34	0.69	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	8.60	0.00	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	10.33	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	56.23	10.59	0.81	1.63	0.00	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	61.97	7.94	1.59	0.00	0.79	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	53.06	4.13	0.00	0.59	2.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	44.26	4.99	1.87	0.31	0.62	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	9.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	68.59	13.01	1.18	2.37	1.18	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	10.27	0.00	7.70	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	59.89	8.26	3.44	4.13	1.38	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	60.37	14.35	2.47	3.96	1.48	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	8.97	3.36	3.36	1.12	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	42.62	12.72	0.64	0.64	0.64	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	39.09	16.12	1.21	0.81	0.40	0.00	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	13.08	4.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	10.14	1.27	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	82.54	20.03	2.43	1.82	4.25	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	31.63	0.00	4.52	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	70.01	15.65	0.82	4.12	0.82	0.82	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.53	6.55	0.20	0.60	0.99	0.40	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	34.07	5.19	0.65	1.95	0.65	0.32	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	37.69	7.13	0.00	2.04	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	204.26	73.50	1.55	6.19	3.09	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	166.31	61.19	2.83	3.07	1.18	1.65	2.83	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	111.20	27.11	9.04	6.02	3.01	0.93	0.93	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	188.04	85.47	0.00	0.00	0.00	0.00	4.27	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	180.84	44.08	4.62	4.11	0.82	2.06	1.54	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	122.78	36.54	3.86	3.63	1.82	2.72	1.59	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	155.49	33.74	2.20	6.11	6.11	0.98	0.73	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	130.64	23.25	3.76	6.20	1.77	1.77	1.33	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	155.06	26.54	8.15	8.67	6.83	1.58	2.10	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	166.65	34.55	6.13	5.62	4.77	1.87	1.70	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	121.08	27.05	2.53	3.79	1.52	0.76	1.52	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	112.22	22.57	2.69	3.52	2.48	0.83	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	178.90	45.06	5.80	7.29	3.64	2.98	1.82	0.99	0.00
mesothelioma cell line:NCI-H226	10846-111E9	133.75	26.24	6.70	5.43	3.08	1.45	1.45	0.90	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	216.43	52.78	2.73	7.35	4.78	0.68	1.71	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	164.38	54.20	1.53	6.36	2.04	1.53	2.80	0.25	0.25
mesothelioma cell line:No36	10857-111G2	157.56	28.71	4.89	6.52	1.30	1.96	1.63	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	143.33	39.02	1.63	4.34	2.44	1.08	0.81	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	168.32	47.98	4.61	4.61	2.69	4.61	2.88	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	139.33	34.31	4.40	4.27	2.56	2.44	2.20	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	77.36	30.33	2.51	2.33	1.44	0.72	1.62	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	156.71	34.28	6.86	5.22	4.57	1.63	1.31	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	87.74	21.62	12.29	3.60	4.24	1.06	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	291.86	55.06	8.52	6.45	2.99	3.46	2.76	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	69.08	24.55	3.81	3.62	2.47	1.33	1.14	0.19	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	164.65	35.66	16.63	2.59	3.70	2.22	0.74	1.29	1.29
myeloma cell line:PCM6	10474-106I6	122.36	26.49	4.35	3.16	2.77	1.19	0.79	1.58	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	362.20	97.40	4.57	10.15	4.06	1.01	4.57	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	220.26	40.01	12.55	7.26	3.14	4.71	2.16	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	66.30	15.71	1.45	1.78	0.89	0.11	0.45	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	71.92	15.81	1.10	1.18	0.15	0.15	0.74	0.29	0.07
nasal epithelial cells, donor2	12227-129F4	93.29	9.94	4.97	0.55	1.66	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	518.33	157.13	14.26	8.51	7.82	6.90	3.22	4.60	0.69
neuroblastoma cell line:NB-1	10539-107G8	200.18	49.76	8.04	6.17	2.06	1.87	1.12	0.37	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	151.63	29.74	13.71	10.33	5.48	3.37	1.69	1.27	0.21
neuroblastoma cell line:NH-12	10555-107I6	411.46	109.39	19.75	10.44	6.89	4.85	2.05	0.75	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	232.24	45.07	5.46	6.17	1.66	2.37	0.95	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	157.11	28.83	9.50	5.07	3.48	2.22	1.58	0.63	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	122.16	28.78	6.84	3.62	3.02	2.42	0.81	0.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	308.35	66.12	10.17	13.35	2.54	14.62	5.72	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	99.81	19.43	2.66	3.19	2.66	0.53	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	104.12	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	9.47	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	244.72	94.20	7.95	8.79	4.90	3.38	1.86	1.18	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	190.52	40.83	8.01	2.40	2.40	0.80	2.40	0.80	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	52.90	13.14	4.17	1.92	1.60	1.28	0.32	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	80.67	14.98	4.20	2.63	1.58	0.00	0.53	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	127.20	30.56	2.34	3.37	3.28	0.94	0.56	0.28	0.56
occipital cortex - adult, donor10196	10172-103C1	86.54	55.63	2.06	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	163.43	45.62	3.22	2.95	1.61	1.61	1.34	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	125.56	28.39	0.73	2.91	0.73	0.73	0.73	0.36	1.46
occipital lobe, adult, donor1	10076-102A4	120.44	34.64	1.31	2.62	4.20	0.00	0.52	0.00	1.31
occipital lobe, fetal, donor1	10073-102A1	134.74	50.20	3.43	3.43	0.43	4.72	2.57	0.43	0.86
occipital pole, adult, pool1	10036-101E9	77.11	19.32	1.34	2.60	1.66	0.08	0.47	0.08	0.24
olfactory region, adult	10195-103E6	127.81	30.57	2.67	4.01	1.53	0.38	0.76	0.00	0.76
optic nerve, donor1	10277-104E7	162.08	62.03	0.00	6.00	2.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	118.81	33.83	2.39	2.51	1.14	1.37	2.05	1.37	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	277.66	88.48	11.54	7.97	5.08	2.06	2.34	2.20	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	158.66	32.51	4.91	2.71	1.35	1.35	1.69	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	192.32	49.90	11.20	6.35	2.66	2.08	2.08	0.58	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	131.70	21.75	3.53	5.29	2.35	0.29	0.29	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	320.48	150.43	2.80	8.41	0.93	1.87	3.74	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	124.48	37.75	3.39	3.39	3.61	2.33	2.54	0.21	0.42
ovary, adult, pool1	10020-101D2	155.84	41.14	2.88	4.54	3.14	0.96	0.70	0.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	163.71	35.75	5.13	5.68	3.12	4.40	1.10	0.37	0.73
pancreas, adult, donor1	10049-101G4	95.00	21.63	1.88	1.88	0.00	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	125.79	43.89	7.27	6.15	3.63	3.63	1.12	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	135.26	26.75	8.35	3.75	3.24	1.53	1.36	1.70	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	291.09	71.53	4.14	4.80	0.99	2.65	2.48	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	107.81	26.63	2.65	4.12	1.83	0.27	0.27	0.37	0.00
parietal cortex, adult, donor10258	10373-105G4	72.67	22.02	1.47	1.47	2.94	1.47	0.73	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	100.63	23.51	3.76	2.82	0.94	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	125.70	44.75	1.43	4.56	2.00	1.14	1.71	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	115.44	30.23	2.56	3.61	1.41	0.26	0.53	0.26	0.35
parietal lobe, fetal, donor1	10072-101I9	197.85	76.62	0.00	0.97	0.00	6.79	0.00	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	137.21	45.61	0.00	2.99	0.75	1.12	0.00	0.00	1.50
parotid gland, adult	10199-103F1	117.17	20.97	0.62	4.93	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	105.81	25.78	1.61	4.30	1.07	0.00	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	191.33	40.35	1.67	3.90	2.05	1.67	0.74	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	85.23	22.73	2.91	3.06	1.31	1.02	0.58	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	125.78	48.38	0.65	3.87	0.65	0.00	1.29	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	143.32	41.45	4.15	3.55	1.78	1.18	1.18	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	171.19	56.44	0.63	8.78	1.25	0.63	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	160.88	40.47	2.02	10.12	2.02	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	178.76	76.61	5.21	5.73	2.61	0.52	5.21	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	131.09	50.22	1.70	5.11	2.55	0.00	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	105.14	24.40	2.47	3.33	1.94	0.86	0.86	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	169.37	54.69	1.99	3.31	1.19	4.63	1.72	0.66	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	123.11	26.61	2.18	2.80	1.25	0.16	1.40	0.00	0.00
pons, adult, pool1	10033-101E6	133.66	31.24	2.32	3.61	1.20	0.69	0.60	0.17	0.43
postcentral gyrus, adult, pool1	10032-101E5	85.43	18.92	2.53	3.23	1.31	0.00	0.35	0.35	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	179.86	23.01	4.18	0.00	4.18	2.09	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	168.82	66.86	8.59	5.68	2.33	1.60	2.48	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	391.86	100.91	14.16	11.98	5.63	3.63	3.81	1.45	0.73
prostate, adult, pool1	10022-101D4	132.32	31.56	2.09	2.81	1.36	0.54	0.54	0.18	0.09
putamen, adult, donor10196	10176-103C5	133.38	38.24	3.54	3.78	2.83	1.42	1.18	0.47	1.18
putamen, adult, donor10252	10152-102I8	103.92	19.61	1.96	3.92	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	60.10	37.16	0.00	3.28	2.19	3.28	3.28	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	126.12	40.59	0.97	6.04	1.21	1.93	0.97	0.00	1.45
putamen, newborn, donor10223	10365-105F5	128.94	47.23	0.75	1.50	0.00	6.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	131.79	48.59	1.75	3.20	1.16	1.16	1.45	0.00	0.00
rectum, fetal, donor1	10067-101I4	72.33	18.08	4.17	1.39	1.39	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	94.98	25.23	2.33	2.54	1.27	0.85	0.64	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	93.61	13.25	0.83	1.66	0.83	0.00	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	108.54	23.36	2.68	4.27	1.19	0.60	0.70	0.20	0.40
retinoblastoma cell line:Y79	10475-106I7	234.60	63.13	12.47	7.79	3.90	4.94	2.34	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	158.85	32.09	14.51	6.64	4.06	1.60	1.23	0.25	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	378.78	122.32	20.53	8.15	6.19	5.06	5.91	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	288.74	33.35	1.52	4.55	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	180.63	23.79	3.72	3.08	1.94	0.97	0.81	0.49	0.32
salivary acinar cells, donor2	11772-123I8	122.13	14.87	2.20	1.79	1.24	0.00	0.28	0.00	0.00
salivary acinar cells, donor3	11773-123I9	252.90	35.09	1.99	3.97	2.65	0.00	0.66	0.00	0.66
salivary gland, adult, pool1	10093-102C3	81.22	17.73	0.00	2.29	2.29	0.00	0.00	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	183.46	49.24	3.88	4.81	2.19	0.93	0.93	0.34	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	141.77	44.08	5.88	4.94	1.18	0.71	1.06	0.35	0.24
seminal vesicle, adult	10201-103F3	178.83	35.98	1.06	4.76	3.17	0.53	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	99.11	20.16	2.43	4.37	2.19	0.97	2.67	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	50.07	12.83	1.51	3.02	0.50	0.25	0.25	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	164.58	46.16	4.01	4.01	3.01	1.00	5.02	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	141.71	33.31	4.70	4.16	3.36	0.67	0.94	0.94	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	279.19	89.86	5.08	5.19	3.43	2.65	1.99	0.88	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	221.28	41.42	3.23	6.32	1.81	1.03	1.16	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	116.33	39.72	2.13	1.42	0.71	0.00	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	149.32	53.97	1.92	3.12	2.16	0.00	1.20	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	38.19	11.06	3.02	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	104.15	20.20	3.16	6.94	0.63	2.52	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	129.74	35.02	11.01	5.67	4.67	6.00	2.67	1.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	342.94	64.93	9.14	9.46	6.62	2.84	5.04	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	191.78	103.89	8.10	6.94	4.63	3.08	10.02	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	450.14	130.71	13.85	9.56	2.97	7.25	5.60	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	460.35	206.05	5.79	9.33	2.41	7.56	10.94	0.97	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	171.07	37.05	24.41	7.63	6.76	2.40	1.74	0.87	0.00
small intestine, adult, pool1	10024-101D6	137.36	31.29	1.55	2.99	2.39	0.96	0.12	0.60	0.12
small intestine, fetal, donor1	10064-101I1	81.57	18.43	1.72	1.47	0.74	0.25	0.49	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	101.55	16.41	3.08	2.05	1.54	1.03	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	111.14	23.00	2.33	2.84	3.10	0.26	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	293.21	34.04	5.09	5.36	1.34	2.14	4.29	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	138.10	45.65	0.46	2.98	0.46	0.23	0.92	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	148.64	39.03	1.18	4.73	1.58	1.18	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	85.78	33.21	0.00	3.46	0.69	0.00	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	101.23	28.66	3.05	3.05	6.10	0.00	1.22	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	149.24	55.11	1.38	2.76	0.92	0.46	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	186.39	27.78	5.82	4.78	3.44	1.49	1.79	0.45	0.45
spleen, adult, pool1	10025-101D7	164.76	45.16	2.86	3.63	1.43	1.43	1.32	0.33	0.33
spleen, fetal, pool1	10044-101F8	107.34	30.75	2.62	3.58	1.59	1.35	0.95	0.64	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	140.26	41.51	3.73	4.87	2.38	1.14	2.38	0.31	1.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	387.16	99.87	12.15	8.16	6.27	3.23	3.61	0.19	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	150.96	51.02	8.04	4.19	1.75	3.49	1.75	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	165.75	31.27	3.91	2.35	0.39	0.78	2.74	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	151.62	41.53	3.49	2.70	1.91	1.69	2.81	0.56	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	154.19	52.95	3.39	4.24	1.27	6.78	1.69	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	216.19	120.15	3.38	6.35	3.38	4.23	4.65	0.00	0.42
stomach, fetal, donor1	10062-101H8	132.43	16.02	4.27	4.27	2.14	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	149.26	35.32	1.14	3.42	1.14	1.71	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	122.75	33.23	2.91	1.87	1.04	0.62	1.25	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	80.69	28.45	0.52	4.14	0.52	1.55	1.55	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	130.01	57.23	0.00	2.12	0.71	2.12	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	189.37	56.86	9.40	7.80	2.52	2.06	2.06	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	93.33	24.41	2.46	4.66	1.78	0.00	0.00	0.17	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	128.21	43.45	2.85	4.99	0.00	3.56	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	129.66	37.80	3.08	4.83	3.08	1.76	1.32	1.32	0.44
tenocyte, donor1	11763-123H8	112.41	17.46	4.54	3.84	2.79	0.35	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	58.37	10.30	3.05	2.67	0.76	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	84.88	15.57	4.08	2.22	2.97	0.00	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	271.43	138.69	17.00	11.73	5.44	13.26	8.84	0.51	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	125.63	45.01	7.71	4.16	2.31	1.85	3.24	0.62	0.31
teratocarcinoma cell line:PA-1	10807-111A6	159.78	58.27	11.93	5.27	2.32	6.82	4.03	0.15	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	131.26	44.69	13.71	6.09	3.68	4.19	3.43	1.02	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	498.05	242.03	16.26	21.56	6.81	9.08	7.94	1.13	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	392.95	129.46	18.10	9.92	7.53	2.18	1.74	0.98	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	174.58	88.92	7.82	4.56	4.89	7.17	1.95	0.65	0.33
testis, adult, pool1	10026-101D8	184.36	61.52	3.97	11.60	5.05	1.40	30.28	0.21	1.50
testis, adult, pool2	10096-102C6	254.41	76.23	2.26	33.38	9.02	2.71	35.18	0.90	5.86
thalamus - adult, donor10196	10168-103B6	112.61	33.12	0.00	3.31	3.31	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	148.78	51.42	5.47	3.59	2.66	1.72	0.47	0.47	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	84.68	33.87	1.54	7.70	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	74.28	19.10	0.49	2.14	0.16	0.16	0.33	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	140.38	50.63	0.00	4.60	1.15	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	122.34	32.96	2.25	4.49	3.75	1.25	1.25	0.25	0.25
throat, fetal, donor1	10061-101H7	87.45	22.24	1.52	2.44	0.91	1.22	0.30	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	224.37	55.45	5.56	4.57	3.97	3.58	0.99	1.79	0.00
thymus, adult, pool1	10027-101D9	130.73	43.05	4.67	4.97	2.68	41.36	3.18	0.40	3.68
thymus, fetal, pool1	10043-101F7	136.53	44.26	3.32	4.57	2.70	61.72	3.01	0.42	3.12
thyroid carcinoma cell line:KHM-5M	10776-110G2	216.06	55.71	2.26	4.52	1.46	2.13	2.66	0.40	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	96.53	25.70	3.91	2.37	1.96	1.12	1.82	0.14	0.14
thyroid, adult, pool1	10028-101E1	124.57	45.35	1.49	2.71	1.96	0.47	0.75	0.09	0.09
thyroid, fetal, donor1	10060-101H6	73.03	22.41	1.05	1.58	1.05	1.32	0.26	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	126.26	46.19	0.00	0.00	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	105.36	23.96	3.02	4.42	1.63	0.00	1.16	0.23	0.00
tongue, fetal, donor1	10059-101H5	68.57	15.76	2.36	1.97	0.39	1.18	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	149.96	37.27	3.41	4.01	2.50	3.21	1.30	0.40	0.30
trachea, adult, pool1	10029-101E2	144.37	32.23	3.44	2.62	2.21	0.82	0.49	0.41	0.08
trachea, fetal, donor1	10058-101H4	71.94	16.16	1.92	1.92	2.31	0.38	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	182.10	34.01	8.15	7.09	1.42	0.00	0.71	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	266.87	84.80	7.80	6.18	4.26	4.96	4.15	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	206.04	81.16	7.36	5.48	4.54	4.54	2.51	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	323.43	57.08	7.61	9.51	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	129.60	24.13	3.64	3.64	2.03	0.93	0.51	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	70.94	12.52	0.00	4.17	0.00	4.17	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	139.23	40.78	1.02	3.41	1.88	0.68	1.37	0.00	0.17
uterus, fetal, donor1	10055-101H1	95.73	20.48	6.66	3.07	3.58	1.54	0.51	0.00	1.02
vagina, adult	10204-103F6	122.13	63.97	0.65	1.29	1.29	0.00	1.29	0.00	1.29
vein, adult	10191-103E2	130.42	33.10	1.10	3.07	2.19	7.23	1.10	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	93.73	23.50	2.40	1.60	0.80	1.07	2.14	0.27	0.53